isosorbide dinitrate has been researched along with Heart Failure in 497 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 227 (45.67) | 18.7374 |
| 1990's | 87 (17.51) | 18.2507 |
| 2000's | 128 (25.75) | 29.6817 |
| 2010's | 47 (9.46) | 24.3611 |
| 2020's | 8 (1.61) | 2.80 |
| Authors | Studies |
|---|---|
| Akinniyi, D; Callier, SL; McPartland, K; Payne, PW; Richardson, TL; Rothstein, MA; Royal, CDM | 1 |
| Becker, C; Besche, N; Boettcher, M; Donath, F; Düngen, HD; Gerrits, M; Hung, J; Karakas, M; Mikus, G; Schulz-Burck, D; Trenk, D; Werner, N | 1 |
| Ahmad, FS; Ahmad, T; Allen, LA | 1 |
| Aparasu, R; Dhoble, A; Goyal, P; Holder, T; Holmes, HM; Kwak, MJ; Onyebeke, C; Wang, Q | 1 |
| Chen, M; Jiang, Z; Li, Y; Peng, Y; Shi, S; Song, J | 1 |
| Abdulla, J; Barasa, A; Bibby, BM; Bruun, NE; Brønnum-Schou, J; Bøtker, HE; Bøttcher, M; Dodt, K; Eiskjær, H; Gislason, G; Gustafsson, F; Hansen, VB; Hassager, C; Hollingdal, M; Høfsten, DE; Jonczy, B; Knudsen, AS; Kristensen, SL; Køber, L; Larsen, AH; Lomholdt, J; Madsen, JS; Mahboubi, K; Mellemkjær, S; Mikkelsen, KV; Møller, J; Nielsen, G; Nielsen, OW; Nørrelund, H; Poenaru, MP; Poulsen, MK; Raymond, I; Refsgaard, J; Schou, M; Serup-Hansen, K; Sillesen, K; Steffensen, FH; Torp-Petersen, C; Vraa, S; Wiggers, H | 1 |
| Amar, M; Faulkenberg, K; Lam, SW; Perez, A; Tang, WHW; Williams, JB | 1 |
| Guglin, M; Ilonze, OJ | 1 |
| Attivi, D; Chambord, J; Gibaud, S; Thuus, V; Zeghmouli, C | 1 |
| Akinboboye, O; Anand, I; Ofili, E; Puckrein, G; Williams, RA; Xu, L | 1 |
| Fonarow, GC; Heidenreich, PA; Ziaeian, B | 1 |
| Cohn, JN | 12 |
| Anand, IS; Arbit, B; Beri, N; Chang, KW; Clopton, P; Cohn, JN; Fox, S; Maisel, AS; Mojaver, S; Nguyen, NH; Tam, SW; Taylor, AL | 1 |
| Dékány, M; Muk, B; Nyolczas, N; Szabó, B | 1 |
| Demers, E; Girouard, C; Grégoire, JP; Kayibanda, JF; Moisan, J | 1 |
| Wu, A | 1 |
| Baez, A; Bazán, C; Camino Willhuber, GO; Fretes, R; Guzman Mentesana, G; Lo Presti, S; Paglini-Oliva, PA; Rivarola, HW; Strauss, M | 1 |
| Butler, J; Felker, GM; Patel, RB; Redfield, MM; Shah, SJ; Vaduganathan, M | 1 |
| Brewster, LM | 1 |
| Lim, WY; Woldman, S | 1 |
| Shi, J; Wang, L; Zhang, Y | 1 |
| Brooks, SC; Diercks, DB; Fermann, GJ; Kidney, R; McCabe, A; Pospisil, C; Salter, N; Seupaul, RA; Wakai, A | 1 |
| Bhatt, DL; Butler, J; Fonarow, GC; Golwala, HB; Hernandez, AF; Liang, L; Stavrakis, S; Thadani, U; Yancy, CW | 1 |
| Eisen, HJ; Feitell, S; Hankins, SR | 1 |
| Colvin-Adams, M; Sharma, A; Yancy, CW | 1 |
| Anand, I; Elkayam, U; Feldman, AM; Ferdinand, KC; Leggett, C; Mancini, D; McNamara, D; Ofili, E; Piña, I | 1 |
| Anand, IS; Cohn, JN; Rector, TS; Taylor, AL; Win, S | 1 |
| Oliveira-Paula, GH | 1 |
| Butler, J; Cole, RT; Gupta, D | 1 |
| Bristow, MR | 1 |
| Cohn, JN; Feldman, AM; Hanley-Yanez, K; McNamara, DM; Tam, SW; Taylor, AL; Worcel, M; Yancy, CW | 1 |
| Anstrom, KJ; Borlaug, BA; Braunwald, E; Chen, HH; Cole, RT; Felker, GM; Joseph, SM; Koepp, GA; Levine, JA; LeWinter, MM; McNulty, SE; Redfield, MM; Reeves, GR; Semigran, MJ; Shah, MR; Shah, SJ; Tang, WH; Tedford, RJ; Velazquez, EJ | 1 |
| Oeser, C | 1 |
| Bhatt, DL; Butler, J; Curtis, LH; Eapen, ZJ; Fonarow, GC; Heidenreich, PA; Hernandez, AF; Khazanie, P; Liang, L; Peterson, ED; Yancy, CW | 1 |
| Taylor, AL | 2 |
| Enseleit, F; Flammer, AJ; Naegele, M; Ruschitzka, F | 1 |
| Yee, J | 1 |
| Braunwald, E; Redfield, MM; Velazquez, EJ | 1 |
| Nichols, WW; O'Rourke, MF; Safar, ME | 1 |
| Akpinar, T; Karan, MA; Tufan, F | 1 |
| Kozhuharov, N; Mueller, C; Sabti, Z | 1 |
| Ba, SA; Cotter, G; Damasceno, A; Davison, BA; Dzudie, A; Edwards, C; Kouam, CK; Mayosi, BM; Milo, O; Mondo, C; Ogah, O; Ogola, E; Ojji, D; Sani, MU; Sliwa, K; Yonga, G | 1 |
| Butler, J; Konstam, MA | 1 |
| Adhyaru, B; Raj, L | 1 |
| Akers, S; Beraun, M; Chirinos, JA; Chittams, J; Haines, PG; Koppula, MR; Rawat, D; Segers, P; Shiva-Kumar, P; Soto-Calderon, H; Townsend, RR; Varakantam, S; Witschey, WR; Zamani, P | 1 |
| Ağır, AA; Baydemir, C; Bozyel, S; Kandemir, AŞ; Karaüzüm, İY; Karaüzüm, K; Kozdağ, G; Ural, D | 1 |
| Norgard, NB; Stark, JE | 1 |
| Dorr, GM; Jones, DS | 1 |
| Ellison, GT; Head, RF; Kahn, JD; Kaufman, JS; Martin, PA | 1 |
| Ferdinand, KC | 3 |
| Ashcroft, R; Ellison, GT; Martin, PA; Smart, A; Tutton, R | 1 |
| Caulfield, T; Harry, S | 1 |
| Reverby, SM | 1 |
| Münzel, T | 1 |
| Cohn, JN; Ghali, JK; Lindenfeld, J; Sabolinski, ML; Tam, SW; Taylor, AL; Worcel, M | 1 |
| Fullerton, SM; Goering, S; Yu, JH | 1 |
| Holm, S | 1 |
| Movsesian, MA; Stehlik, J | 1 |
| Jacob, RG; Thadani, U | 1 |
| Cohn, JN; Feldman, AM; Ghali, JK; Janosko, K; McNamara, DM; Ofili, E; Sabolinski, ML; Tam, SW; Taylor, AL; Tobelmann, P; Venkitachalam, L; Worcel, M; Yancy, C | 1 |
| Abrahams, Z; Francis, GS; Mullens, W; Sokos, G; Starling, RC; Tang, WH; Taylor, DO; Young, JB | 1 |
| Coons, SJ | 1 |
| Emsermann, CB; Fairclough, D; Hamman, R; Hammermeister, KE; Ho, M; Phibbs, S; Plomondon, M; Steiner, JF; Valuck, R; West, D | 1 |
| De Silva, DS; Izumiya, Y; Sam, F; Sato, K; Wilson, RM | 1 |
| Hsich, EM; Piña, IL | 1 |
| Ishizawar, D; Yancy, C | 1 |
| Bonham, VL; Cooper, LA; Frank, D; Gallagher, TH; Odunlami, AO; Price, EG; Sellers, SL | 1 |
| Feldman, A; Yancy, CW | 1 |
| Royal, CD; Rusert, BM | 1 |
| Inomata, T; Izumi, T; Koitabashi, T; Maekawa, E; Mizutani, T; Shinagawa, H; Takeuchi, I; Watanabe, I; Yanagisawa, T | 1 |
| Norgard, NB; Prescott, GM | 1 |
| Butler, J; Cole, RT; Georgiopoulou, VV; Gheorghiade, M; Kalogeropoulos, AP; Quyyumi, A; Yancy, C | 1 |
| Cohn, JN; Mitchell, JE; O'Neal, W; Tam, SW; Taylor, AL; Trivedi, K; Worcel, M | 1 |
| Hare, JM; Mann, DL; Taylor, AL | 1 |
| Archambault, WT; Cohn, JN; Ghali, JK; Sabolinski, ML; Tam, SW; Taylor, AL; Worcel, M; Ziesche, S | 1 |
| Ferdinand, DP; Ferdinand, KC; Serrano, CC | 1 |
| Cohn, JN; Ferdinand, K; Franciosa, JA; Loscalzo, J; Ofili, E; Olukotun, A; Taylor, AL; Worcel, M; Yancy, CW; Ziesche, S | 1 |
| Cohn, JN; Franciosa, JA; Taylor, AL; Worcel, M | 1 |
| Gould, PA; Kaye, DM | 1 |
| Afzal, R; Anker, SD; Coats, AJ; Cohn, JN; Negassa, A; Poole-Wilson, PA; Yusuf, S | 1 |
| de Luca, L; Fedele, F; Gattis, WA; Gheorghiade, M; Klein, L; O'Connor, CM; Vitarelli, A; Zampino, M | 1 |
| Akiyama, K; Suzuki, S; Taniguchi, M; Tsurikisawa, N | 1 |
| Kahn, J | 5 |
| Chatterjee, K | 2 |
| Ikeda, U; Takahashi, M; Yoshioka, T | 1 |
| Adams, K; Carson, P; Cohn, JN; D'Agostino, R; Ferdinand, K; Sabolinski, M; Taylor, AL; Taylor, M; Worcel, M; Yancy, C; Ziesche, S | 1 |
| Bloche, MG | 2 |
| Hare, JM | 1 |
| Tutton, R | 1 |
| Petsko, GA | 1 |
| Duan, XZ; Lu, ZZ; Wang, SW; Wu, XL; Xu, H; Yang, DY | 1 |
| Brandt, D | 1 |
| Payne, JW | 1 |
| Massie, BM | 1 |
| Cooper, RS; Moran, AE | 1 |
| Eisenberger, AB | 1 |
| Bellin, EY | 1 |
| Chow, AY | 1 |
| Peota, C | 1 |
| Saul, S | 4 |
| Wadman, M | 1 |
| Kahn, JD | 2 |
| Aronow, WS | 2 |
| Czap, A | 1 |
| Dunlap, ME; Ibrahim, OA | 1 |
| Thompson, CA | 1 |
| Senior, K | 1 |
| Bowser, R | 1 |
| Fiscella, K | 1 |
| Bitar, F; Elkayam, U | 1 |
| Puckrein, G; Yancy, CW | 1 |
| Gottsäter, A; Ohlin, AK; Ohlin, H; Tingberg, E | 1 |
| Angus, DC; Ghali, JK; Linde-Zwirble, WT; Sabolinski, ML; Tam, SW; Villagra, VG; Winkelmayer, WC; Worcel, M | 1 |
| Gilbert, M; Laustsen, G; Wimett, L | 1 |
| Atar, D; Hodt, A; Steine, K | 1 |
| Hoffman, S | 1 |
| Ruel, MD | 1 |
| Horinaka, S; Kobayashi, N; Matsuoka, H; Mori, Y; Yagi, H | 1 |
| Ginsburg, GS; Haga, SB | 1 |
| Aguiar-Souto, P; Garcia-Pavia, P; Ortigosa, FJ; Silva-Melchor, L | 1 |
| Cheng, JW | 1 |
| Puckrein, G | 1 |
| Adorisio, R; De Luca, L; Gheorghiade, M; Rossi, J | 1 |
| Franciosa, JA | 5 |
| Bibbins-Domingo, K; Fernandez, A | 2 |
| Stockbridge, NL; Temple, R | 1 |
| Adams, KF; Anand, IS; Archambault, WT; Cohn, JN; Olukotun, AY; Rector, TS; Sabolinski, ML; Tam, SW; Taylor, AL; Worcel, M | 1 |
| Flack, JM | 1 |
| Duster, T | 1 |
| Echols, MR; Yancy, CW | 1 |
| Adams, K; Carson, P; Cohn, JN; Ferdinand, K; Ofili, E; Olukotun, AY; Sabolinski, ML; Tam, SW; Taylor, AL; Taylor, M; Worcel, M; Yancy, CW; Ziesche, S | 1 |
| Colvin-Adams, M; Taylor, AL | 1 |
| Lapu-Bula, R; Ofili, E | 1 |
| Kolbaia, NG; Ol'binskaia, LI; Sizova, ZhM | 1 |
| Ghali, JK | 1 |
| Fujita, H | 1 |
| Hoover, EL | 1 |
| Sade, RM | 1 |
| Matthews, GE | 1 |
| Anand, IS; Cohn, JN; Sabolinski, ML; Tam, SW; Taylor, AL; Worcel, M | 1 |
| Crawley, L | 1 |
| Archambault, WT; Braman, VM; Franciosa, JA; Ghali, JK; Sabolinski, ML; Worcel, M; Yancy, CW | 1 |
| Decaro, MV; Graham, MG; Rosen, D | 1 |
| Cohn, JN; Curry, CL; Ferdinand, KC; Ghali, JK; Lindenfeld, J; Sabolinski, ML; Tam, SW; Taylor, AL; Worcel, M | 1 |
| Daar, AS; Hardy, B; Séguin, B; Singer, PA | 1 |
| Huggett, B | 1 |
| Bleske, BE; Chavey, WE; Hogikyan, RV; Kesterson, SK; Nicklas, JM; Van Harrison, R | 1 |
| Levine, TB | 2 |
| Haueisen, H; Kübler, W; Leinberger, H; Mäurer, W; Schuler, G | 1 |
| Ahuja, RC; Hussain, M; Nelson, GI; Silke, B; Taylor, SH | 2 |
| Shevchenko, VA | 1 |
| Ahuja, RC; Forsyth, DR; Nelson, GI; Silke, B; Taylor, SH; Verma, SP; Walker, C | 1 |
| Swedberg, K | 1 |
| Albani, A; Artese, D; Di Tomasso, E | 1 |
| Hecht, HS; Hopkins, JM; Karahalios, SE; Ormiston, JA; Rose, JG; Schnugg, SJ; Singh, BN | 1 |
| Bailly, P; Cassagnes, J; Jallut, H; Lamaison, D; Lusson, JR; Teyssonneyre, B | 1 |
| Dunkman, WB; Franciosa, JA; Leddy, CL | 1 |
| Huss, P; Leier, CV; Magorien, RD; Unverferth, DV | 2 |
| Packer, M | 3 |
| Hiramori, K; Ikeda, M; Kimata, S; Niitani, H; Takano, T; Tanaka, K | 1 |
| Blakeley, C; Tinker, J | 1 |
| Ciafone, RA | 1 |
| Bounhoure, JP; Breton, J; Fauvel, JM; Kayanakis, JG; Maillet, J | 1 |
| Hatano, M; Hibiya, K; Ichikawa, M; Nagasawa, M; Ozawa, Y; Saito, S; Tamura, Y; Tomobe, K; Yumikura, S | 1 |
| Kodama, K; Koretsune, Y; Nanto, S; Taniura, K | 1 |
| Inden, M; Itou, M; Kawahira, S; Morimoto, Y; Nakano, T; Noda, E; Takasaki, H; Takezawa, H; Tanimura, H | 1 |
| Solonovich, TG | 1 |
| Richardson, PJ; Timmis, AD | 1 |
| Bussmann, WD | 2 |
| Bardet, J; Beaumont, D; Bourdarias, JP; Dubourg, O; Farcot, JC; Ferrier, A; Gueret, P; Rigaud, M; Terdjman, M | 1 |
| Araki, Y; Fujita, K; Sakaguchi, K; Sawada, M; Tanaka, N | 1 |
| Taylor, SH | 1 |
| Forsyth, DR; Hussain, M; Nelson, GI; Silke, B; Taylor, SH; Verma, SP | 1 |
| Gwilt, DJ; Petri, M; Reid, DS | 1 |
| Kothiala, A; Mehta, NC; Patel, HR; Ramnani, K; Shah, CP | 1 |
| Fung, HL; Parker, JO; Ruggirello, D; Stone, JA | 1 |
| Igarashi, T; Ohhara, H; Takeda, M | 1 |
| Leier, CV; Magorien, RD; Mehegan, JP; Unverferth, BJ; Unverferth, DV | 1 |
| Hayakawa, H; Kimura, E; Obayashi, K; Rose, HB; Seino, Y; Takano, T; Vyden, JK | 1 |
| Matsui, S; Murakami, E; Murakami, H; Takekoshi, N | 1 |
| Ida, T; Ikeshita, M; Osaka, S; Shoji, T; Takano, T; Takei, H; Tanaka, K; Yamate, N | 1 |
| Medina, N; Packer, M; Yushak, M | 1 |
| Abrams, J | 6 |
| Cohn, JN; Franciosa, JA | 3 |
| Arnoux, F; Bory, M; Clavier, P; Djiane, P; Egre, A; Serradimigni, A | 1 |
| Haughom, F; Kramer, B; Massie, B | 1 |
| Mantle, JA; Rackley, CE; Rogers, WJ; Russell, RO | 1 |
| Bambach, D; Cattaneo, SM; Goldberg, RJ; Leier, CV; Thompson, MJ; Unverferth, DV | 1 |
| Rodger, JC | 1 |
| Baigrie, R; Burns, R; Feiglin, D; Haq, A; Hilton, D; McLaughlin, P; Rakowski, H; Tihal, H | 1 |
| Azzollini, M; Domenichini, R; Mafrici, A; Maggiulli, G; Mauri, F | 2 |
| Blasini, R; Blümel, G; Froer, KL; Rudolph, W | 1 |
| Bayliss, J; Canepa-Anson, R; Norell, M; Poole-Wilson, PA; Reuben, SR; Sutton, GC | 1 |
| Kadota, K; Kambara, H; Kawai, C; Kawashita, K; Saimyoji, H | 1 |
| Grigor'iants, RA; Lobova, NM; Mareev, VIu; Naumov, VG | 1 |
| Barretto, AC; Cardoso, Lde S; Dauar, D; Del Nero, E; Lima, EV; Savioli, RM; Wajngarten, M | 1 |
| Gasanova, AS; Serbin, VI | 1 |
| Elazar, E; Neufeld, HN; Rabinowitz, B; Tamari, I | 1 |
| Chatterjee, K; Parmley, WW; Rouleau, JL | 1 |
| Kolibash, AJ; Leier, CV; Magorien, RD; Robinson, JL | 1 |
| Budini, A; Cesari, GP; Chiesa, R; Colonna, PL; Frascione, P; Manfrin, M; Schicchi, F | 1 |
| Ferraro, N; Wilson, JR | 2 |
| Dubejko, J; Kutarski, A; Widomska-Czekajska, T | 1 |
| Haughom, F; Kramer, B; Massie, BM; Shen, E | 1 |
| Bödigheimer, K; Delius, W; Nowak, FG | 1 |
| Greenberg, BH; Walsh, WF | 1 |
| Gorlin, R; Medina, N; Meller, J; Packer, M; Yushak, M | 1 |
| Kübler, W; Mehmel, HC; Ruffmann, K; Schwarz, F; Stockins, B | 1 |
| Markiewicz, W; Peled, B; Rochman, J | 1 |
| Mantle, JA; Papapietro, SE; Rackley, CE; Rogers, WJ; Russell, RO | 1 |
| Bertolasi, CA; Pérez Baliño, N; Riccitelli, MA; Trongé, J; Villamayor, RM | 1 |
| Hirshfeld, J; Untereker, W; Wilson, JR | 1 |
| Bubenheimer, P; Hauf, GF; Lönne, E; Roskamm, H | 1 |
| Chadani, T; Fujita, S; Masuya, K; Matsui, S; Murakami, E; Murakami, H; Nomura, M; Takekoshi, N; Tsuji, S | 1 |
| Bracchetti, D; Cantelli, I; Naccarella, F; Pavesi, PC | 1 |
| Ballantyne, D; Baxter, RH; Clark, RS; McGuinness, JB; Weir, JI | 1 |
| Cohn, JN; Franciosa, JA; Hale, KA; Pierpont, G | 1 |
| Dymond, DS; Spurrell, RA; Stephens, JD | 1 |
| Banim, SO; Spurrell, RA; Stephens, JD | 1 |
| Inoue, H; Mifune, J; Murakami, M; Sugiura, M; Ueda, K | 1 |
| Dymond, DS; Rees, GM; Spurrell, RA; Stephens, JD; Stone, DL | 1 |
| Leier, CV; Magorien, RD; Unverferth, DV | 1 |
| Barretto, AC; Del Nero, E; Lima, EV; Mady, C; Martinelli Filho, M; Savioli, RM | 1 |
| Dustan, HP; Mantle, JA; Rackley, CE; Rogers, WJ; Russell, RO; Tauxe, WN | 1 |
| Cohn, JN; Franciosa, JA; Goldsmith, SR | 1 |
| Fantini, F; Franchi, F; Michelucci, A; Morace, G; Porciani, MC | 1 |
| Himmler, FC; Klein, G; Kutschera, I; Sauer, E; Schmidt, G; Wirtzfeld, A | 1 |
| Andrews, R; Cowley, AJ; Evans, A; Walsh, JT | 1 |
| Elkayam, U; Mehra, A; Ostrzega, E; Shotan, A; Vasquez-Johnson, J | 1 |
| Ahlner, J; Torfgård, KE | 1 |
| Do, YS; Elkayam, U; Fisher, DA; Hsueh, W; Hurst, A; Johnson, JV; Mehra, A; Ostrzega, E; Shotan, A | 1 |
| Hori, M; Kamada, T; Sato, H; Takeda, H; Yokoyama, H | 1 |
| Baker, DW; Bottorff, M; Konstam, MA; Pitt, B | 1 |
| Bauer, JA; Fung, HL | 1 |
| Dagan, T; Halon, DA; Hasanein, J; Lewis, BS; Makhoul, N | 1 |
| Berkenboom, G; de Cannière, D; Staroukine, M; Unger, P; Vachiery, JL | 1 |
| Halon, DA; Hardoff, R; Lewis, BS; Rosenfeld, T | 2 |
| Akatsuka, N | 1 |
| Elkayam, U; Hsueh, W; Mehra, A; Ostrzega, E; Shotan, A; Vasquez-Johnson, J | 1 |
| Faggiano, P; Ghizzoni, G; Lombardi, C; Rusconi, C; Sorgato, A; Spedini, C | 1 |
| Bhandari, B; Chakraborty, S; Ghose, JC; Mondal, M | 1 |
| Hayashi, H; Ikeda, J; Kubo, K; Kuroda, T; Sano, T; Suzuki, F | 1 |
| Hayashi, H; Ikeda, J; Karasawa, A; Kubo, K; Moriyama, T; Suzuki, F | 1 |
| Carson, PE; Cohn, JN; Dunkman, WB; Farrell, L; Fletcher, RD; Johnson, GR | 1 |
| Cintron, G; Cobb, F; Cohn, JN; Francis, G; Johnson, G | 1 |
| Cohn, JN; Hughes, CV; Johnson, G; Wong, M | 1 |
| Carson, P; Cohn, JN; Francis, GS; Johnson, G | 1 |
| Cintron, G; Cohn, JN; Francis, G; Goldman, S; Johnson, G; Smith, R | 1 |
| Carson, P; Cintron, GB; Cohn, JN; Fletcher, RD; Johnson, G; Orndorff, J | 1 |
| Cohn, JN; Francis, GS; Goldman, S; Johnson, G; Rector, TS; Simon, A | 1 |
| Cohn, JN; Fletcher, R; Johnson, GR; Loeb, H; Rector, T; Shabetai, R; Smith, R; Tristani, F | 1 |
| Cobb, FR; Cohn, JN; Johnson, G; Tristani, F; Ziesche, S | 1 |
| Bhat, G; Cohn, JN; Hughes, V; Johnson, G; Lopez, B; Shabetai, R; Wong, M | 1 |
| Cohn, JN; Daniels, G; Dunkman, WB; Farrell, L; Henrick, A; Johnson, G; Rector, TS; Smith, B | 1 |
| Cohn, JN; Cremo, R; Henrick, A; Johnson, G; Loeb, HS; Smith, R; Wilson, J | 1 |
| Bhat, G; Carson, PE; Cohn, JN; Dunkman, WB; Farrell, L; Johnson, GR | 1 |
| Algarra, F; Almenar, L; Gimeno, JV; Martínez Dolz, L; Miró, V; Mora, V; Moreno, MT; Salvador, A; Sotillo, J | 1 |
| Carson, P; Cohn, J; Fletcher, R; Johnson, G | 1 |
| Duggal, C; Khosla, S; Somberg, JC | 1 |
| Parker, JO | 1 |
| Cosín Aguilar, J; Cruz Fernández, JM; de Teresa Galván, E; Ferreira Montero, IJ; López-Sendón, J; Soler Soler, J; Tamargo Menéndez, J | 1 |
| Goldberg, D; Goldstein, S; Lesch, M; Levine, AB; Levine, TB; Narins, B | 1 |
| Lazebnik, LB | 1 |
| Arai, M; Aso, N; Hama, J; Ishikawa, K; Kamata, N; Kanamasa, K; Katori, Y; Kimura, A; Naito, T; Nakai, S; Ogawa, I; Oyaizu, M; Takenaka, T; Yabushita, H; Yamamoto, K; Yamamoto, T | 1 |
| Agostoni, P; Alimento, M; Contini, M; Guazzi, M; Marenzi, G | 1 |
| Billings, J; Keteyian, SJ; Lesch, M; Levine, AB; Levine, TB; Vincenzi, A | 1 |
| Keteyian, SJ; Lesch, M; Levine, AB; Levine, TB; Narins, B | 1 |
| Chelimsky-Fallick, C; Fonarow, GC; Hamilton, MA; Kartashov, A; Moriguchi, JD; Steimle, AE; Stevenson, LW; Tillisch, JH | 1 |
| Adams, KF; Ellis, ML; Patterson, JH; Williamson, KM | 1 |
| Struthers, AD; Yee, KM | 1 |
| Beranek, G; Braksator, W; Chmielewski, M; Dłuzniewski, M; Król, J; Krysztofiak, H; Kuch, M; Mamcarz, A | 1 |
| Dernellis, JM; Toutouzas, PK; Vyssoulis, GP; Zacharoulis, AA | 1 |
| Beyerle, A; Hähnel, I; Lampen, M; Lehmann, G; Reiniger, G; Schömig, A | 1 |
| Blatt, A; Cotter, G; Faigenberg, Z; Golik, A; Kaluski, E; Koren, M; Marghitay, D; Metzkor, E; Miller, R; Moshkovitz, Y; Shaham, O; Simovitz, A; Zaidenstein, R | 1 |
| D'iakov, VM; Kazimirovskaia, VB; Koval'chuk, SF; Sabadyshin, RO; Slipak, OIa | 1 |
| Levine, AB; Levine, TB; Muller, C | 1 |
| Keteyian, SJ; Levine, AB; Levine, TB; Narins, B | 1 |
| Aoyagi, T; Fujita, H; Hirata, Y; Matsumoto, A; Momomura, S; Omata, M; Sata, M; Sugiura, S | 1 |
| Caspi, A; Ermer, W; Lewis, BS; Markiewicz, W; Rabinowitz, B; Rosenfeld, T; Schlesinger, Z; Sclarovsky, S | 1 |
| Carson, P; Cohn, JN; Johnson, G; Ziesche, S | 1 |
| Drazner, MH; Solomon, MA; Thompson, B; Yancy, CW | 1 |
| Ol'binskaia, LI; Sizova, ZhM; Ushakova, AV | 1 |
| Kaminski, P; Levine, AB; Levine, TB; Stomel, RJ | 1 |
| Hayashi, T; Ishikawa, K; Kanamasa, K; Kimura, A; Kitayama, K; Miyataka, M; Takenaka, T; Yabushita, H; Yamamoto, T | 1 |
| Hidaka, T; Ohsuzu, F; Shinohara, T; Suzuki, K; Yanai, H | 1 |
| Elliott, WG; Levine, AB; Levine, TB; Narins, B; Stomel, RJ | 1 |
| Abraham, WT; Wagoner, LE | 1 |
| Craven, R | 1 |
| Henze, E; Hetzel, J; Hetzel, M; Hombach, V; Wieshammer, S | 1 |
| Cardin, S; Leung, TK; Li, D; Nattel, S; Pang, L; Shinagawa, K; Wang, Z | 1 |
| Rich, MW | 1 |
| Abdulatif, AS; El-Medany, AH; Mahgoub, AA | 1 |
| Sterz, H | 1 |
| Enenkel, W | 1 |
| Brundage, BH; Chatterjee, K; Gelberg, H; Massie, B; Ports, TA; Rubin, S | 1 |
| Kimata, S | 1 |
| Baitsch, G; Bertel, O; Burkart, F; Elsässer, S; Ritz, R | 1 |
| Bussmann, WD; Kaltenbach, M; Lemke, R; Lippok, R | 1 |
| Besse, P; Larnaudie, B; Page, A; Pic, A; Videau, P | 1 |
| Kennedy, RD | 1 |
| Amsterdam, EA; Bommer, WJ; Mason, DT; Miller, RR; Williams, DO | 1 |
| Bussmann, WD; Kaltenbach, M; Löhner, J | 3 |
| Cohn, JN; Franciosa, JA; Nordstrom, LA | 1 |
| Ito, T; Ito, Y; Matsumoto, S | 1 |
| Figueras, J; Forrester, JS; Ogawa, T; Singh, BN; Swan, HJ; Taylor, WR | 1 |
| Amsterdam, EA; Awan, NA; DeMaria, AN; Lee, G; Mason, DT | 1 |
| Shah, PK | 1 |
| Ogawa, T; Rose, HB; Takano, TT; Vyden, JK | 1 |
| Schröder, R | 1 |
| Chatterjee, K; Greenberg, B; Hart, R; Massie, B; Parmley, WW; Werner, J | 1 |
| Manfrin, M; Prati, PL | 1 |
| Camm, AJ; Spurrell, RA; Stephens, JD | 1 |
| Imhof, P | 1 |
| Contreras, M; Lanas, F; Miranda, V; Opazo, JA; Saavedra, J; Stockins, B | 1 |
| Barbis, V; Di Lorenzo, M; Gambelli, G; Giovannini, E; Greco, C; Manfrin, M; Pezzella, A; Pittorino, L; Prati, PL; Signoretti, P | 1 |
| Iturriaga, J; Lanas, F; Opazo, JA; Saavedra, J; Salvatici, R | 1 |
| Cohn, JN; Franciosa, JA; Pierpont, GL | 1 |
| Kai, I; Kondo, T; Matsui, E; Niwa, T; Ogasawara, B; Okubo, M; Sassa, H; Watanabe, E | 1 |
| McAlpin, RN | 1 |
| Hirosawa, K; Kimata, S; Nakai, K; Ogawa, T; Osamura, Y; Takahashi, S | 1 |
| Bleifeld, W; Hanrath, P; Kupper, W; Mathey, D | 1 |
| Camm, J; Spurrell, R; Stephens, J | 1 |
| Dymond, D; Spurrell, R; Stephens, J | 1 |
| Calon, AH; Caracta, AR; Carambas, CR; Damato, AN; Dhatt, MS; Gomes, JA; Moran, HE | 1 |
| Burdhan, A; Chhetri, MK; Dasgupta, A; Ghose, JC | 1 |
| Bossi, M; Cataldo, G; Colombo, A; De Vita, C; Fiorista, F; Gronda, E; Mauri, F; Pirelli, S; Rovelli, F | 1 |
| de Guzman, M; Durairaj, SK; Haywood, LJ; Venkataraman, K | 1 |
| Cohn, JN; Franciosa, JA; Mikulic, E | 1 |
| Berens, SC; Bramowitz, AD; Kovick, RB; Shine, KI; Tillisch, JH | 1 |
| da Luz, PL; Forrester, JS | 1 |
| Pascal, N | 1 |
| Chatterjee, K; Drew, D; Klausner, SC; Parmley, WW; Polansky, J; Zacherle, B | 1 |
| Mantle, JA; Moraski, RE; Rackley, CE; Rogers, WJ; Russel, RO | 1 |
| Beck, OA; Habel, F; Hochrein, H; Wolf, R | 1 |
| Baligadoo, S; Barritault, L; Chiche, P | 1 |
| Ganimede, F; Iliceto, N; Pierfelice, O; Roma, F; Taurino, L | 1 |
| Mantle, JA; Moraski, RE; Rackley, CE; Russell, RO | 1 |
| Plawner, R | 1 |
| Chatterjee, K; Forrester, JS; Ganz, W; Gray, R; Swan, HJ; Vyden, JK | 1 |
| Glocke, M; Stein, G; Teufel, W | 1 |
| Brandt, R; Goppel, L; Loracher, C; Rudolph, W; Thiede, D | 1 |
| Reynolds, GW; Richmond, A; Silke, B; Taylor, SH; Verma, SP | 2 |
| Ageev, FT; Grigor'iants, RA; Kazeĭ, DV; Mareev, VIu; Shevliagin, SA | 1 |
| Akehi, N; Imai, K; Kimura, H; Ohgitani, N; Taniura, T; Yamada, M | 1 |
| Cholewa, M; Dryjański, T; Gawor, Z; Górski, L; Kaczkowska-Marusik, E; Kuś, W; Markiewicz, K | 1 |
| Elkayam, U; Johnson, JV; Mehra, A; Ostrzega, E; Shotan, A | 1 |
| Kuboki, K; Kuramoto, K; Kuwajima, I; Maeda, S; Ohkawa, S; Sakai, M; Ueda, K | 1 |
| Isnard, R; Komajda, M; Lechat, P | 1 |
| Beauchet, A; Bejuit, R; Bourdarias, JP; Chikli, F; Delorme, G; Dubourg, O; Jondeau, G; Weber, S | 1 |
| Albanese, E; Chelimsky-Fallick, C; Fonarow, GC; Hamilton, MA; Luu, M; Moriguchi, JD; Stevenson, LW; Tillisch, JH; Walden, JA | 1 |
| Thadani, U | 1 |
| Anderson, KA | 1 |
| Elkayam, U; Jamison, M; Johnston, JV; Kulick, D; Mehra, A; Ostrzega, E; Rahimtoola, SH; Roth, A; Shotan, A | 1 |
| Hasebe, N; Honda, H; Maruyama, J; Matsuhashi, H; Onodera, S; Tobise, K; Yamashita, H | 1 |
| Cobb, F; Cohn, JN; Dunkman, WB; Francis, G; Johnson, G; Loeb, H; Smith, R; Tristani, F; Wong, M; Ziesche, S | 1 |
| Lüderitz, B; Manz, M; Wagner, WL | 1 |
| Baldenkov, GN; Mazaev, AV; Mukharliamov, NM; Negrescu, EV; Sazonova, LN; Tkachuk, VA | 1 |
| Marmor, A | 1 |
| Dirschinger, J; Hall, D; Rudolph, W | 1 |
| Dück, KD; Richard, F | 1 |
| Klein, R; Sharir, T | 1 |
| Broks-Bratkowska, B; Bubiński, R; Cholewa, M; Dryjański, T; Gawor, Z; Górski, L; Kuś, W; Markiewicz, K | 1 |
| Amin, J; Elkayam, U; Mehra, A; Rahimtoola, SH; Vasquez, J; Weber, L | 1 |
| Feuereisl, R; Jezek, V; Jezková, J; Michaljanic, A; Niederle, P | 1 |
| Gottlieb, SS; Kessler, PD; Lee, WH; Packer, M | 1 |
| Herpai, Z; Moser, G | 1 |
| Silke, B; Taylor, SH; Verma, SP | 1 |
| Assmann, I; Dueck, KD | 1 |
| Bachmann, K; Wortmann, A | 1 |
| Engelmann, L; Frömmel, H; Kucher, A; Wetzler, G | 1 |
| Nötges, A; Traber, U; Wolf, R | 1 |
| Barin, E; Hoschl, R; Nelson, GI; Stokes, GS; Wilkes, NP | 1 |
| Assereto, R; Baggio, E; Gandini, R; Maraffi, F; Massari, D; Megali, R; Montella, S; Pozzoli, G; Vargiu, B | 1 |
| Halon, DA; Hardoff, R; Lewis, BS | 1 |
| Francis, GS | 1 |
| Bhans, A; Debbas, N; Dews, I; Jubber, A; Marks, C; Stephens, J; Vandenburg, M; Woodings, D | 1 |
| Baldenkov, GN; Men'shikov, MIu; Mukharliamov, NM; Negresku, EV; Sazonova, LN | 1 |
| Lee, WH; Medina, N; Packer, M; Yushak, M | 2 |
| Hatano, M; Hibiya, K; Kaseda, N; Moriuchi, M; Ozawa, Y; Saito, S; Tamura, Y; Tokutake, E; Tsuji, M; Yumikura, S | 1 |
| Sal'nikov, SN; Vertkin, AL; Zharov, EI | 1 |
| Daskalov, TR | 1 |
| Hiramatsu, S; Katoh, Y; Kikawada, R; Kobayashi, A; Muramatsu, J | 1 |
| Thadani, U; Whitsett, TL | 1 |
| Schneeweiss, A | 1 |
| Thadani, U; Whitsett, T | 1 |
| Blaha, M; Roubalík, P; Stejfa, M; Vítovec, J | 1 |
| Amaro Cendón, A; Gil de la Peña, M; González-Juanatey, JR; Vega Fernández, M | 1 |
| Anand, IS; Gurden, J; Harris, P; Poole-Wilson, PA; Wanless, RB | 1 |
| Parsons, RS | 1 |
| Fujisue, R; Iwasaki, T; Ohyanagi, M; Todo, Y | 1 |
| Blaha, M; Krifta, P; Roubalík, P; Sobotová, D; Stejfa, M; Studeník, P; Vítovec, J | 1 |
| Chouraqui, P; Katz, A; Neufeld, HN; Rabinowitz, B; Shotan, A | 1 |
| Elkayam, U; Kulick, D; McIntosh, N; Rahimtoola, SH; Roth, A | 1 |
| Canale, C; Caponnetto, S; Masperone, MA; Terrachini, V | 1 |
| Archibald, DG; Cohn, JN; Dunkman, WB; Flohr, KH; Franciosa, JA; Francis, GS; Harston, WE; Jacobs, W; Tristani, FE; Ziesche, S | 2 |
| Burgess, JH; Chatterjee, K; Cousineau, D; Daly, P; Rouleau, JL | 1 |
| Kanto, JH | 1 |
| Alpert, JS; Blondheim, D; Marmor, A; Plich, M; Schneeweiss, A; Sharir, T | 1 |
| Gammage, MD; Murray, RG | 1 |
| Hutton, I; Martin, W; McGhie, AI; Tweddel, AC | 2 |
| Marks, C; Stephens, JD; Vandenburg, MJ; Woodings, D | 1 |
| Kassirskiĭ, SG; Ordian, MM; Sobol', IuS | 1 |
| Gaĭdukova, NI; Kirichenko, LL; Solov'eva, FV | 1 |
| Gammage, MD; Littler, WA; Murray, RG | 1 |
| Koshlia, VI | 1 |
| Bufka, V; Kohout, P; Sochor, K; Sova, Z | 1 |
| Borisov, BE; Ivanov, AP; Loginova, IF; Serbin, VI | 1 |
| Aguglia, F; De Marzio, P; Gnecchi, M; Morelli, S | 1 |
| de Roquefeuil, F; Goupil, C | 1 |
| Parmley, WW | 1 |
| Schroeder, JS | 1 |
| Hayakawa, H; Hiramori, K; Hirosawa, K; Hosoda, S; Inoue, M; Kambara, H; Kawai, C; Kimata, S; Takano, T; Yamaguchi, H | 1 |
| Beck, OA | 1 |
| Leier, CV | 1 |
| Ageev, FT; Evdokimova, NKh; Mareev, VIu; Mukharliamov, NM; Novikov, SV | 1 |
| Barbakova, AA; Karbasnikova, GV; Valeeva, RM; Zabel'ian, OM; Zhuikova, AA | 1 |
| Bucher, HJ | 1 |
| Leier, CV; Magorien, RD; Ren, JH; Unverferth, DV | 1 |
| Ruksin, VV | 1 |
| Daskalov, TR; Malamov, E | 1 |
| Inden, M; Itoh, M; Kawahira, S; Nakano, T; Noda, E; Takasaki, H; Takezawa, H; Tanimura, H | 1 |
| Reynolds, JL | 1 |
| Russek, HI | 1 |
| Cohn, JN; Franciosa, JA; Mathew, KJ; Snow, JA | 1 |
| Cohn, JN; Fabie, A; Franciosa, JA; Jose, E; Mikulic, E | 1 |
| Nager, F | 1 |
| Brody, W; Criley, JM | 1 |
88 review(s) available for isosorbide dinitrate and Heart Failure
| Article | Year |
|---|---|
How do we define high and low dose intensity of heart failure medications: a scoping review.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Heart Failure; Humans; Isosorbide Dinitrate; Stroke Volume | 2023 |
Combination of Hydralazine and Isosorbide-Dinitrate in the Treatment of Patients with Heart Failure with Reduced Ejection Fraction.
Topics: Clinical Trials as Topic; Drug Interactions; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Stroke Volume | 2018 |
Heart Failure.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Cardiac Rehabilitation; Cardiovascular Agents; Coronary Artery Disease; Defibrillators, Implantable; Diabetes Complications; Diagnostic Techniques, Cardiovascular; Digoxin; Diuretics; Heart Failure; Hospitalization; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Ivabradine; Life Style; Mineralocorticoid Receptor Antagonists; Palliative Care; Primary Prevention; Referral and Consultation; Risk Factors | 2018 |
Pharmacological management of chronic heart failure: old drugs, new drugs and new indications.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiovascular Agents; Chronic Disease; Digoxin; Drug Combinations; Heart Failure; Heart Failure, Systolic; Humans; Hydralazine; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists | 2013 |
Nitrates for acute heart failure syndromes.
Topics: Acute Disease; Adult; Heart Failure; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin; Randomized Controlled Trials as Topic; Syndrome; Vasodilator Agents | 2013 |
Adjunctive therapy and management of the transition of care in patients with heart failure.
Topics: Adaptation, Psychological; Adrenergic beta-Antagonists; Alcohol Drinking; Ambulatory Care; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiac Resynchronization Therapy; Cardiotonic Agents; Continuity of Patient Care; Defibrillators, Implantable; Deinstitutionalization; Diet; Digoxin; Diuretics; Drug Combinations; Exercise Therapy; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Mineralocorticoid Receptor Antagonists; Palliative Care; Risk Reduction Behavior; Secondary Prevention; Self Care; Smoking Cessation; Substance-Related Disorders | 2014 |
Heart failure in African Americans: disparities can be overcome.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black or African American; Cardiotonic Agents; Defibrillators, Implantable; Digoxin; Drug Combinations; Health Status Disparities; Heart Failure; Heart Transplantation; Heart-Assist Devices; Humans; Hydralazine; Hypertension; Incidence; Isosorbide Dinitrate; Mineralocorticoid Receptor Antagonists; Prevalence; Quality of Health Care; Socioeconomic Factors; Vasodilator Agents | 2014 |
Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial.
Topics: Black or African American; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Practice Guidelines as Topic | 2014 |
Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiotonic Agents; Cardiovascular Agents; Digoxin; Diuretics; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists; Neprilysin; Stroke Volume; Vasodilator Agents | 2016 |
An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF).
Topics: Adrenergic beta-Antagonists; American Heart Association; Amides; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antihypertensive Agents; Atrial Natriuretic Factor; Benzazepines; Biphenyl Compounds; Calcium Channel Blockers; Cardiology; Cardiotonic Agents; Cardiovascular Agents; Digoxin; Diuretics; Drug Combinations; Erythropoietin; Evidence-Based Medicine; Fumarates; Heart Failure; Hematinics; Humans; Hydralazine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iron; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Societies, Medical; Stroke Volume; Tetrazoles; United States; Valsartan; Vasodilator Agents | 2016 |
Pharmacotherapy for heart failure with left ventricular dysfunction: beyond angiotensin-converting enzyme inhibitors and beta-blockers.
Topics: Angiotensin II Type 1 Receptor Blockers; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Mineralocorticoid Receptor Antagonists; Prescription Fees; Renin-Angiotensin System; Ventricular Dysfunction, Left | 2008 |
Fixed-dose isosorbide dinitrate-hydralazine: race-based cardiovascular medicine benefit or mirage?
Topics: Black or African American; Black People; Drug Combinations; Evidence-Based Medicine; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Vasodilator Agents | 2008 |
Genotyping the future: scientists' expectations about race/ ethnicity after BiDil.
Topics: Drug Combinations; Genetics, Population; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Pharmacogenetics; Racial Groups; Sex; Vasodilator Agents | 2008 |
[Recent findings on nitrates: their action, bioactivation and development of tolerance].
Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; Coronary Disease; Drug Tolerance; Endothelium, Vascular; Guanylate Cyclase; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Molsidomine; Nitrates; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Oxidative Stress; Pentaerythritol Tetranitrate; Reactive Oxygen Species; Vasodilation; Vasodilator Agents | 2008 |
Heart failure in women: a need for prospective data.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cardiac Pacing, Artificial; Digoxin; Female; Heart Failure; Heart-Assist Devices; Humans; Hydralazine; Isosorbide Dinitrate; Male; Mineralocorticoid Receptor Antagonists; Pacemaker, Artificial; Platelet Aggregation Inhibitors; Risk Factors; Sex Factors; Women's Health | 2009 |
Racial differences in heart failure therapeutics.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Black or African American; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitric Oxide; Nitric Oxide Donors; Phenotype; Polymorphism, Genetic; Renin-Angiotensin System; Risk Assessment; United States | 2010 |
Future of personalized pharmacotherapy in chronic heart failure patients.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Black or African American; Digoxin; Female; Genetic Markers; Heart Failure; Humans; Incidence; Isosorbide Dinitrate; Male; Precision Medicine; Sex Factors; United States; White People | 2011 |
Hydralazine and isosorbide dinitrate in heart failure: historical perspective, mechanisms, and future directions.
Topics: Animals; Black or African American; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Exercise Tolerance; Forecasting; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Stroke Volume | 2011 |
Contemporary treatment of heart failure: is there adequate evidence to support a unique strategy for African-Americans? Con position.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black or African American; Black People; Clinical Trials as Topic; Coronary Disease; Heart Failure; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Risk Factors | 2002 |
Clinical treatment regimens for chronic heart failure: a review.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Cardiotonic Agents; Digoxin; Diuretics; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Pacemaker, Artificial; Spironolactone; Vasodilator Agents | 2002 |
Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiac Output, Low; Cardiotonic Agents; Clinical Trials as Topic; Diuretics; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Systole; Vasodilator Agents | 2003 |
Congestive heart failure: what should be the initial therapy and why?
Topics: Adrenergic Antagonists; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Drug Therapy, Combination; Exercise; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Vasodilator Agents | 2002 |
How a drug becomes "ethnic": law, commerce, and the production of racial categories in medicine.
Topics: Black or African American; Cardiovascular Agents; Commerce; Drug Approval; Drug Combinations; Drug Labeling; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Retrospective Studies; United States | 2004 |
[Nitric oxide and heart failure].
Topics: Administration, Inhalation; Angiotensin-Converting Enzyme Inhibitors; Animals; Endothelial Cells; Heart Failure; Humans; Isosorbide Dinitrate; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III | 2004 |
Combination pharmacologic therapies for heart failure: what next after angiotensin-converting enzyme inhibitors and beta-blockers?
Topics: Acetanilides; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Drug Therapy, Combination; Enzyme Inhibitors; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Mineralocorticoid Receptor Antagonists; Piperazines; Pyridines; Ranolazine; Tetrazoles; Tolvaptan; Vasodilator Agents | 2005 |
Effects of nitrates and hydralazine in heart failure: clinical evidence before the african american heart failure trial.
Topics: Animals; Black or African American; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Heart Failure; Heart Function Tests; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Risk Assessment; Severity of Illness Index; Stroke Volume; Survival Rate; Treatment Outcome | 2005 |
The African American Heart Failure Trial: a clinical trial update.
Topics: Adult; Aged; Black or African American; Cause of Death; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitric Oxide Donors; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Survival Analysis; Treatment Outcome; Vasodilator Agents | 2005 |
A-HeFT: old dog, new endothelial tricks.
Topics: Black or African American; Drug Therapy, Combination; Endothelium, Vascular; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Treatment Outcome; United States; Vasodilator Agents | 2005 |
[Medical and ventilatory treatment of acute heart failure].
Topics: Acute Disease; Adrenergic beta-Agonists; Cardiotonic Agents; Continuous Positive Airway Pressure; Diuretics; Dobutamine; Furosemide; Heart Failure; Humans; Hydrazones; Isosorbide Dinitrate; Natriuretic Agents; Natriuretic Peptide, Brain; Nitric Oxide Donors; Oxygen Inhalation Therapy; Practice Guidelines as Topic; Pyridazines; Simendan; Vasodilator Agents | 2006 |
A review of isosorbide dinitrate and hydralazine in the management of heart failure in black patients, with a focus on a new fixed-dose combination.
Topics: Black People; Drug Therapy, Combination; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitric Oxide Donors; Randomized Controlled Trials as Topic; Vasodilator Agents | 2006 |
Pharmacological treatment of chronic heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Digitalis Glycosides; Diuretics; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Mineralocorticoid Receptor Antagonists | 2006 |
Fixed combination isosorbide dinitrate-hydralazine for nitric-oxide-enhancing therapy in heart failure.
Topics: Cardiac Output, Low; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitric Oxide; Nitric Oxide Donors | 2006 |
Medicalisation of race.
Topics: Age Distribution; Aged; Antineoplastic Agents; Black or African American; Clinical Trials as Topic; Drug Approval; Drug Combinations; Gefitinib; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Lung Neoplasms; Middle Aged; Patents as Topic; Quinazolines; United States; United States Food and Drug Administration | 2007 |
Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure.
Topics: Black or African American; Disease Progression; Drug Combinations; Endothelium, Vascular; Genetic Predisposition to Disease; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitric Oxide; Oxidative Stress; Patient Selection; Severity of Illness Index; Treatment Outcome; Vasodilator Agents | 2006 |
Isosorbide dinitrate-hydralazine improves outcomes in African Americans with heart failure.
Topics: Black or African American; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Treatment Outcome; United States | 2007 |
African American heart failure trial: role of endothelial dysfunction and heart failure in African Americans.
Topics: Adult; Aged; Black or African American; Drug Therapy, Combination; Endothelium, Vascular; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Middle Aged; Nitric Oxide Donors; Randomized Controlled Trials as Topic | 2007 |
From hypertension to heart failure: role of nitric oxide-mediated endothelial dysfunction and emerging insights from myocardial contrast echocardiography.
Topics: Aged; Black or African American; Drug Therapy, Combination; Echocardiography; Female; Heart Failure; Humans; Hypertension; Isosorbide Dinitrate; Male; Nitric Oxide; Nitric Oxide Donors; Randomized Controlled Trials as Topic; Superoxides; Ventricular Remodeling | 2007 |
[Hypotension associated with heart failure].
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Cardiac Output; Chronic Disease; Diuretics; Heart Failure; Humans; Hypotension; Isosorbide Dinitrate; Mineralocorticoid Receptor Antagonists; Renal Dialysis; Systemic Inflammatory Response Syndrome; Vascular Resistance | 2007 |
Evidence-based treatment of chronic heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Defibrillators, Implantable; Digitalis Glycosides; Diuretics; Drug Combinations; Evidence-Based Medicine; Exercise; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Mineralocorticoid Receptor Antagonists; Vasodilator Agents | 2007 |
Pharmacologic management of heart failure caused by systolic dysfunction.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Digoxin; Diuretics; Heart Failure; Humans; Hydrazines; Isosorbide Dinitrate; Severity of Illness Index; Systole; Vasodilator Agents | 2008 |
Current concepts in the treatment of congestive heart failure.
Topics: Calcium Channel Blockers; Captopril; Digitalis Glycosides; Dipeptides; Diuretics; Enalapril; Enzyme Inhibitors; Heart Failure; Humans; Hydralazine; Hypernatremia; Isosorbide Dinitrate; Nitroprusside; Prazosin; Vasoconstriction | 1984 |
[Treatment of heart failure in ischemic heart disease with beta-adrenostimulators and peripheral vasodilators].
Topics: Adrenergic beta-Agonists; Captopril; Cardiotonic Agents; Coronary Disease; Dobutamine; Dopamine; Heart Failure; Humans; Hydralazine; Isoproterenol; Isosorbide Dinitrate; Nitroprusside; Nonachlazine; Phentolamine; Practolol; Prazosin; Prenalterol; Vasodilator Agents | 1983 |
Isosorbide dinitrate in clinical practice.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina Pectoris, Variant; Blood Pressure; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Heart Failure; Humans; Isosorbide Dinitrate; Nifedipine | 1984 |
Conceptual dilemmas in the classification of vasodilator drugs for severe chronic heart failure. Advocacy of a pragmatic approach to the selection of a therapeutic agent.
Topics: Captopril; Chronic Disease; Coronary Circulation; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Vasodilator Agents | 1984 |
Vasodilators in acute circulatory failure.
Topics: Albuterol; Captopril; Chlorpromazine; Heart Failure; Humans; Isosorbide Dinitrate; Nitroglycerin; Nitroprusside; Phentolamine; Vasodilator Agents | 1983 |
[Effect of vasodilator agents in chronic heart failure].
Topics: Cardiomegaly; Clinical Trials as Topic; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Phentolamine; Placebos; Prazosin; Quinazolines; Vasodilator Agents | 1981 |
Nitrate tolerance and dependence.
Topics: Ambulatory Care; Angina Pectoris; Animals; Cardiovascular Diseases; Dogs; Drug Tolerance; Heart Failure; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin; Occupational Medicine; Propranolol; Rabbits; Rats; Substance-Related Disorders; Time Factors | 1980 |
Vasodilator therapy of congestive heart failure.
Topics: Aortic Valve Insufficiency; Captopril; Dobutamine; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Minoxidil; Mitral Valve Insufficiency; Nitroglycerin; Nitroprusside; Phentolamine; Physical Exertion; Piperazines; Prazosin; Quinazolines; Time Factors; Vasodilator Agents | 1980 |
[Peripheral vasodilators in the treatment of heart failure].
Topics: Cardiac Output; Cardiomyopathies; Coronary Circulation; Droperidol; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitrates; Nitroprusside; Phentolamine; Piperazines; Prazosin; Quinazolines; Rheumatic Heart Disease; Stroke Volume; Vasodilator Agents | 1982 |
Vasodilators in heart failure. Conclusions from V-HeFT II and rationale for V-HeFT III.
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Enalapril; Exercise; Felodipine; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Norepinephrine; Oxygen Consumption; Prognosis; Stroke Volume; Survival Analysis | 1994 |
Plasma norepinephrine and mortality.
Topics: Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Norepinephrine; Prognosis; Sympathetic Nervous System; Ventricular Dysfunction, Left | 1995 |
Mechanisms of action of nitrates.
Topics: Angina Pectoris; Blood Platelets; Cyclic GMP-Dependent Protein Kinases; Cytochrome P-450 Enzyme System; Esterases; Glutathione Transferase; Heart; Heart Failure; Humans; Isosorbide Dinitrate; Muscle Relaxation; Muscle, Smooth, Vascular; Myocardial Infarction; Nitrates; Nitroglycerin; Oxygen Consumption; Structure-Activity Relationship; Vasodilator Agents | 1994 |
Management of heart failure. I. Pharmacologic treatment.
Topics: Angiotensin-Converting Enzyme Inhibitors; Decision Support Techniques; Digoxin; Diuretics; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; United States; United States Agency for Healthcare Research and Quality; Ventricular Dysfunction, Left | 1994 |
Mechanisms of nitrate tolerance.
Topics: Angina Pectoris; Animals; Drug Administration Routes; Drug Therapy, Combination; Drug Tolerance; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin; Sulfhydryl Compounds; Vascular Resistance | 1994 |
[Vasodilator therapy in cardiac failure].
Topics: Adrenergic beta-Antagonists; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitroglycerin; Norepinephrine; Renin-Angiotensin System; Sympathetic Nervous System; Vasodilator Agents | 1993 |
Successful heart failure therapy is effective antiarrhythmia therapy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Failure; Humans; Isosorbide Dinitrate; Ventricular Dysfunction, Left | 1996 |
[Neurohormonal factors in heart failure. I].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Aldosterone; Angiotensin II; Autonomic Nervous System; Clinical Trials as Topic; Female; Heart; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Receptors, Adrenergic; Renin-Angiotensin System; Vasodilator Agents | 1996 |
Can drug effects on mortality in heart failure be predicted by any surrogate measure?
Topics: Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Biomarkers; Calcium Channel Blockers; Deoxyepinephrine; Dopamine Agonists; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate | 1997 |
Left ventricle and arteries: structure, function, hormones, and disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arginine Vasopressin; Drug Combinations; Epinephrine; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitroprusside; Prazosin; Randomized Controlled Trials as Topic; Renin; Renin-Angiotensin System; Stroke Volume; Survival Analysis; Time Factors; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Remodeling | 2001 |
Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
Topics: Adrenergic beta-Antagonists; Aged; Aging; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Clinical Trials as Topic; Diagnosis, Differential; Diastole; Digoxin; Diuretics; Female; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prevalence; Prognosis; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Stroke Volume; Ventricular Dysfunction, Left | 2001 |
Medical management of mild-to-moderate heart failure before the advent of beta blockers.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Anticoagulants; Antihypertensive Agents; Calcium Channel Blockers; Clinical Trials as Topic; Diuretics; Heart Failure; Humans; Hypertension; Isosorbide Dinitrate; Randomized Controlled Trials as Topic; Severity of Illness Index; Vasodilator Agents | 2001 |
Management of heart failure in the elderly.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Digoxin; Diuretics; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Patient Education as Topic; Self Care | 2002 |
[New aspects in the treatment of acute cardiac insufficiency].
Topics: Adrenergic beta-Antagonists; Clonidine; Diazoxide; Digitalis Glycosides; Diuretics; Droperidol; Fentanyl; Fibrinolytic Agents; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Microcirculation; Myocardial Contraction; Neuroleptanalgesia; Nitroprusside; Phentolamine; Prazosin; Respiration, Artificial; Vascular Resistance; Vasodilator Agents | 1978 |
[Cardiac therapy in the old patient].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Body Water; Calcium; Clonidine; Digitalis Glycosides; Diuretics; Dose-Response Relationship, Drug; Drug Tolerance; Glomerular Filtration Rate; Heart Diseases; Heart Failure; Humans; Hypertension; Isosorbide Dinitrate; Kidney; Methyldopa; Middle Aged; Nitroglycerin; Prazosin; Reserpine; Water-Electrolyte Balance | 1979 |
[Vasodilator therapy in heart failure (author's transl)].
Topics: Aortic Valve Insufficiency; Coronary Vessels; Heart Failure; Heart Septal Defects, Ventricular; Humans; Isosorbide Dinitrate; Mitral Valve Insufficiency; Mitral Valve Stenosis; Myocardial Infarction; Nitroglycerin; Nitroprusside; Vasodilator Agents | 1978 |
Drug therapy for cardiovascular disease in the aged.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Bacterial Agents; Arrhythmias, Cardiac; Benzothiadiazines; Cardiac Rehabilitation; Cardiac Surgical Procedures; Cardiovascular Diseases; Coronary Disease; Delayed-Action Preparations; Digoxin; Diuretics; Endocarditis; Female; Heart Failure; Humans; Hypertension; Hypertension, Malignant; Hyperthyroidism; Hypothyroidism; Isosorbide Dinitrate; Male; Methyldopa; Middle Aged; Nitroglycerin; Sodium Chloride Symporter Inhibitors | 1975 |
[Chronic heart failure and vasodilator therapy].
Topics: Aged; Aortic Valve Insufficiency; Chronic Disease; Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Mitral Valve Insufficiency; Nitroprusside; Vasodilator Agents | 1978 |
[Vasodilator therapy of congestive heart failure].
Topics: Acute Disease; Blood Pressure; Cardiac Output; Chronic Disease; Heart Failure; Humans; Isosorbide Dinitrate; Myocardium; Nitroglycerin; Nitroprusside; Oxygen Consumption; Phentolamine; Vascular Resistance; Vasodilator Agents | 1977 |
[Vasodilator agents in the treatment of heart failure].
Topics: Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Minoxidil; Nitroglycerin; Nitroprusside; Phentolamine; Prazosin; Vasodilator Agents | 1978 |
[Treatment of cardiac failure with vasodilators (author's transl)].
Topics: Cardiac Glycosides; Diuretics; Drug Therapy, Combination; Heart Failure; Hydralazine; Hypotension; Isosorbide Dinitrate; Nitroglycerin; Nitroprusside; Phenoxybenzamine; Phentolamine; Prazosin; Vasodilator Agents | 1978 |
Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction.
Topics: Blood Pressure; Cardiac Output; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Isosorbide Dinitrate; Myocardial Infarction | 1976 |
[Nitrate derivatives and cardiac insufficiency].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Drug Tolerance; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Middle Aged | 1992 |
Lessons from V-HeFT: questions for V-HeFT II and the future therapy of heart failure.
Topics: Enalapril; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Prazosin; Survival Rate; Vasodilator Agents | 1991 |
A practical guide to nitrate use.
Topics: Angina Pectoris; Heart Failure; Humans; Isosorbide Dinitrate; Myocardial Infarction; Nitroglycerin; Pulmonary Edema | 1991 |
Studies of Left Ventricular Dysfunction (SOLVD)--new hope for heart failure.
Topics: Drug Therapy, Combination; Enalapril; Heart Failure; Hospitalization; Humans; Hydralazine; Isosorbide Dinitrate; Stroke Volume; Survival Rate | 1991 |
Relationship between the inhibition of receptor-induced increase in cytosolic free calcium concentration and the vasodilator effects of nitrates in patients with congestive heart failure.
Topics: Adult; Blood Platelets; Calcium; Heart Failure; Humans; Isosorbide Dinitrate; Middle Aged; Nifedipine; Nitrates; Nitroglycerin; Nitroprusside; Plethysmography | 1990 |
[Nitrates in the treatment of heart failure].
Topics: Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin | 1990 |
Heart failure management: the impact of drug therapy on survival.
Topics: Captopril; Clinical Trials as Topic; Digitalis Glycosides; Diuretics; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Time Factors | 1988 |
Glyceryl trinitrate (nitroglycerin) and the organic nitrates. Choosing the method of administration.
Topics: Angina Pectoris; Heart Failure; Humans; Isosorbide Dinitrate; Myocardial Infarction; Nitrates; Nitroglycerin | 1987 |
Nitrate therapy: continuous or pulse dosing.
Topics: Angina Pectoris; Delayed-Action Preparations; Drug Tolerance; Heart Failure; Humans; Isosorbide Dinitrate; Nitroglycerin | 1987 |
Relationship of pharmacokinetic and pharmacodynamic properties of the organic nitrates.
Topics: Angina Pectoris; Animals; Dose-Response Relationship, Drug; Drug Tolerance; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Nitroglycerin | 1988 |
Isosorbide dinitrate and exercise performance in patients with congestive heart failure.
Topics: Angina Pectoris; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Oxygen Consumption; Physical Exertion; Pulmonary Wedge Pressure; Time Factors | 1985 |
Role of isosorbide dinitrate in management of chronic congestive heart failure.
Topics: Administration, Oral; Chronic Disease; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Heart Failure; Heart Rate; Humans; Hydralazine; Isosorbide Dinitrate; Myocardial Contraction; Stroke Volume | 1985 |
Combination therapy with isosorbide dinitrate: current status and the future.
Topics: Angina Pectoris; Coronary Vasospasm; Diltiazem; Drug Therapy, Combination; Esophageal Achalasia; Exercise Test; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nifedipine; Nitroprusside; Propranolol; Verapamil | 1985 |
Hemodynamic effects of nitroglycerin and long-acting nitrates.
Topics: Angina Pectoris; Arteries; Arterioles; Blood Circulation; Coronary Circulation; Coronary Disease; Extremities; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Lung; Nitroglycerin; Regional Blood Flow; Splanchnic Circulation; Sympathetic Nervous System; Time Factors; Veins | 1985 |
Nitrate tolerance.
Topics: Administration, Oral; Administration, Topical; Angina Pectoris; Drug Administration Schedule; Drug Tolerance; Emulsions; Heart Failure; Humans; Isosorbide Dinitrate; Nitroglycerin; Ointments; Time Factors | 1985 |
Mechanisms of nitrate action in patients with severe left ventricular failure: conceptual problems with the theory of venosequestration.
Topics: Arteries; Blood Volume; Heart Failure; Heart Ventricles; Humans; Isosorbide Dinitrate; Nitroglycerin; Pulmonary Circulation; Stroke Volume; Vascular Resistance; Vasodilation; Venous Pressure | 1985 |
Pharmacology of nitroglycerin and long-acting nitrates.
Topics: Absorption; Administration, Oral; Administration, Topical; Angina Pectoris; Animals; Cheek; Delayed-Action Preparations; Drug Tolerance; Heart Failure; Humans; Infusions, Parenteral; Isosorbide Dinitrate; Kinetics; Mouth Floor; Mouth Mucosa; Muscle, Smooth, Vascular; Nitrates; Nitroglycerin; Vasodilator Agents | 1985 |
119 trial(s) available for isosorbide dinitrate and Heart Failure
| Article | Year |
|---|---|
Vericiguat in combination with isosorbide mononitrate in patients with chronic coronary syndromes: The randomized, phase Ib, VISOR study.
Topics: Adult; Double-Blind Method; Heart Failure; Heterocyclic Compounds, 2-Ring; Humans; Isosorbide Dinitrate; Pyrimidines; Syndrome | 2022 |
The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 × 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chr
Topics: Aged; Chronic Disease; Denmark; Diabetes Mellitus; Double-Blind Method; Drug Combinations; Female; Heart Failure; Hospitalization; Humans; Hydralazine; Hypoglycemic Agents; Isosorbide Dinitrate; Male; Metformin; Myocardial Infarction; Placebos; Prediabetic State; Stroke; Stroke Volume | 2021 |
Heart Failure With Recovered Ejection Fraction in African Americans: Results From the African-American Heart Failure Trial.
Topics: Adrenergic beta-Antagonists; Black or African American; Cause of Death; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prevalence; Recovery of Function; Stroke Volume; Time Factors; Treatment Outcome; United States; Vasodilator Agents; Ventricular Function, Left | 2018 |
Physical Activity, Quality of Life, and Biomarkers in Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction (from the NEAT-HFpEF Trial).
Topics: Accelerometry; Aged; Aged, 80 and over; Atrial Fibrillation; Biomarkers; Cross-Over Studies; Double-Blind Method; Exercise; Exercise Tolerance; Female; Follow-Up Studies; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Protein Precursors; Quality of Life; Stroke Volume | 2019 |
Influences of simvastatin on vascular endothelial function of patients with coronary heart disease complicated with congestive heart failure.
Topics: Adult; Aged; Calcitonin Gene-Related Peptide; Coronary Disease; Digoxin; Drug Therapy, Combination; Endothelins; Endothelium, Vascular; Female; Heart Failure; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isosorbide Dinitrate; Male; Middle Aged; Nitric Oxide; Simvastatin | 2013 |
Effect of fixed-dose combination of isosorbide dinitrate and hydralazine on all hospitalizations and on 30-day readmission rates in patients with heart failure: results from the African-American Heart Failure Trial.
Topics: Black or African American; Dose-Response Relationship, Drug; Drug Combinations; Female; Follow-Up Studies; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Patient Readmission; Recurrence; Survival Rate; Time Factors; Treatment Outcome; United States | 2014 |
G-protein beta-3 subunit genotype predicts enhanced benefit of fixed-dose isosorbide dinitrate and hydralazine: results of A-HeFT.
Topics: Analysis of Variance; Black or African American; Disease-Free Survival; Drug Combinations; Female; Genotype; Heart Failure; Heterotrimeric GTP-Binding Proteins; Humans; Hydralazine; Isosorbide Dinitrate; Length of Stay; Male; Middle Aged; Polymorphism, Single Nucleotide; Quality of Life; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Left | 2014 |
Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction.
Topics: Accelerometry; Aged; Cross-Over Studies; Double-Blind Method; Exercise Tolerance; Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Motor Activity; Natriuretic Peptide, Brain; Peptide Fragments; Quality of Life; Stroke Volume; Vasodilator Agents; Walking | 2015 |
Bi treatment with hydralazine/nitrates vs. placebo in Africans admitted with acute HEart Failure (BA-HEF).
Topics: Acute Disease; Adult; Africa South of the Sahara; Aged; Black People; Double-Blind Method; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Middle Aged; Prospective Studies; Vasodilator Agents | 2016 |
Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction.
Topics: Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Echocardiography, Doppler; Female; Fibrosis; Heart Failure; Heart Ventricles; Humans; Hydralazine; Hypertrophy, Left Ventricular; Isosorbide Dinitrate; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardium; Pilot Projects; Stroke Volume; Vasodilator Agents; Ventricular Function, Left; Ventricular Remodeling | 2017 |
Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial.
Topics: Black People; Blood Pressure; Diastole; Drug Combinations; Female; Gene Frequency; Genotype; Heart Failure; Humans; Hydralazine; Introns; Isosorbide Dinitrate; Male; Middle Aged; Nitric Oxide Synthase Type III; Phenotype; Polymorphism, Genetic; Promoter Regions, Genetic; Stroke Volume; Vasodilator Agents; White People | 2009 |
Atrial fibrillation and mortality in African American patients with heart failure: results from the African American Heart Failure Trial (A-HeFT).
Topics: Atrial Fibrillation; Black or African American; Drug Combinations; Female; Follow-Up Studies; Heart Failure; Humans; Hydralazine; Incidence; Isosorbide Dinitrate; Male; Middle Aged; Prevalence; Prognosis; Quality of Life; Risk Factors; Stroke Volume; Survival Rate; United States | 2011 |
Effect of fixed-dose combined isosorbide dinitrate/hydralazine in elderly patients in the African-American heart failure trial.
Topics: Age Factors; Aged; Aging; Black or African American; Double-Blind Method; Drug Therapy, Combination; Female; Health Status Indicators; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Kaplan-Meier Estimate; Male; Middle Aged; Nitric Oxide Donors; Quality of Life; Time; Treatment Outcome; United States; Vasodilator Agents | 2012 |
African-American Heart Failure Trial (A-HeFT): rationale, design, and methodology.
Topics: Adolescent; Adult; Aged; Black People; Double-Blind Method; Drug Combinations; Female; Heart Failure; Humans; Hydralazine; Informed Consent; Isosorbide Dinitrate; Male; Middle Aged; Patient Selection; Research Design; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Left | 2002 |
The African-American Heart Failure Trial: background, rationale and significance.
Topics: Black or African American; Cardiovascular Agents; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Research Design | 2002 |
Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.
Topics: Adult; Aged; Black People; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Nitric Oxide Donors; Quality of Life; Survival Analysis; Treatment Outcome; Vasodilator Agents | 2004 |
[A clinical study on manshuailing oral liquid in treating elder patients with congestive heart failure of type heart and kidney yang deficiency].
Topics: Administration, Oral; Adult; Aged; Cardiotonic Agents; Combined Modality Therapy; Diagnosis, Differential; Digoxin; Drug Combinations; Drugs, Chinese Herbal; Female; Heart Failure; Heart Function Tests; Humans; Hydrochlorothiazide; Isosorbide Dinitrate; Male; Medicine, Chinese Traditional; Middle Aged; Phytotherapy; Plants, Medicinal; Sodium Chloride Symporter Inhibitors; Vasodilator Agents; Yang Deficiency | 2003 |
Lipid peroxidation is not increased in heart failure patients on modern pharmacological therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Comorbidity; Delayed-Action Preparations; Dinoprost; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Lipid Peroxidation; Losartan; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Nitric Oxide Donors; Oxidative Stress; Ramipril; Stroke Volume; Ultrasonography; Ventricular Dysfunction, Left | 2006 |
Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial.
Topics: Adult; Aged; Arthralgia; Biomarkers; Black or African American; Cardiovascular Agents; Cause of Death; Disease-Free Survival; Dizziness; Double-Blind Method; Drug Combinations; Heart Failure; Heart Transplantation; Hospitalization; Humans; Hydralazine; Hypotension; Isosorbide Dinitrate; Kaplan-Meier Estimate; Middle Aged; Mortality; Natriuretic Peptide, Brain; Nitric Oxide Donors; Proportional Hazards Models; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Vasodilator Agents | 2007 |
Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: results from A-HeFT.
Topics: Adult; Aged; Black or African American; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Natriuretic Peptide, Brain; Stroke Volume; Treatment Outcome; Ultrasonography; Ventricular Remodeling | 2007 |
Evidence for the continued safety and tolerability of fixed-dose isosorbide dinitrate/hydralazine in patients with chronic heart failure (the extension to African-American Heart Failure Trial).
Topics: Administration, Oral; Black or African American; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Patient Compliance; Quality of Life; Stroke Volume; Survival Rate; Treatment Outcome; United States | 2007 |
Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Black or African American; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Treatment Outcome; Vasodilator Agents | 2007 |
Dose-dependent haemodynamic response to prenalterol in patients with congestive heart failure.
Topics: Administration, Oral; Adrenergic beta-Agonists; Cardiac Catheterization; Cardiac Output; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epinephrine; Heart Failure; Heart Rate; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Norepinephrine; Practolol; Prenalterol; Pulmonary Wedge Pressure; Stroke Volume | 1982 |
Haemodynamic advantages of isosorbide dinitrate over frusemide in acute heart-failure following myocardial infarction.
Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Furosemide; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Random Allocation | 1983 |
Frusemide or isosorbide dinitrate for acute heart failure?
Topics: Acute Disease; Clinical Trials as Topic; Furosemide; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Isosorbide Dinitrate | 1983 |
Hemodynamic trial of sequential treatment with diuretic, vasodilator, and positive inotropic drugs in left ventricular failure following acute myocardial infarction.
Topics: Adrenergic beta-Agonists; Adult; Cardiotonic Agents; Drug Therapy, Combination; Furosemide; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Practolol; Prenalterol; Random Allocation | 1984 |
Isosorbide dinitrate in clinical practice.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina Pectoris, Variant; Blood Pressure; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Heart Failure; Humans; Isosorbide Dinitrate; Nifedipine | 1984 |
Hemodynamic effects of vasodilators and long-term response in heart failure.
Topics: Antihypertensive Agents; Captopril; Dipeptides; Enalapril; Exercise Test; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Minoxidil; Oxygen Consumption; Pulmonary Wedge Pressure; Stroke Volume; Vascular Resistance; Vasodilator Agents | 1984 |
Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.
Topics: Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Echocardiography; Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Physical Exertion; Pulmonary Artery; Pulmonary Wedge Pressure; Systole; Vascular Resistance | 1983 |
[Effects of isosorbide dinitrate tape (TY-0081) on congestive heart failure: results of multicenter study].
Topics: Adult; Aged; Clinical Trials as Topic; Dosage Forms; Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1984 |
[Effect of vasodilator agents in chronic heart failure].
Topics: Cardiomegaly; Clinical Trials as Topic; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Phentolamine; Placebos; Prazosin; Quinazolines; Vasodilator Agents | 1981 |
Controlled, eight-hour haemodynamic study of a sustained-release formulation of isosorbide dinitrate in moderate left ventricular failure.
Topics: Delayed-Action Preparations; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Time Factors | 1984 |
Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction.
Topics: Adult; Blood Pressure; Cardiac Output; Drug Therapy, Combination; Furosemide; Heart Failure; Heart Rate; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Random Allocation; Stroke Volume; Vascular Resistance | 1983 |
Management of acute heart failure following myocardial infarction: hemodynamic advantages of isosorbide dinitrate over frusemide.
Topics: Adult; Aged; Furosemide; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction | 1983 |
Acute and chronic isosorbide dinitrate therapy in congestive heart failure: demonstration of improved exercise capacity and differing arterial and venous tolerance during chronic administration.
Topics: Heart Failure; Humans; Isosorbide Dinitrate; Physical Exertion; Pulmonary Wedge Pressure; Vascular Resistance | 1983 |
Regression of myocardial cellular hypertrophy with vasodilator therapy in chronic congestive heart failure associated with idiopathic dilated cardiomyopathy.
Topics: Aged; Cardiomyopathy, Hypertrophic; Drug Combinations; Female; Heart; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Myocardium | 1983 |
[Comparative study of three oral nitrate derivatives. A hemodynamic assessment in 10 patients with chronic heart failure (author's transl)].
Topics: Administration, Oral; Adult; Blood Pressure; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Pentaerythritol Tetranitrate; Pulmonary Artery | 1980 |
Acute haemodynamic comparison of amrinone and pirbuterol in chronic heart failure. Additional effects of isosorbide dinitrate.
Topics: Adult; Aged; Aminopyridines; Amrinone; Cardiotonic Agents; Chronic Disease; Drug Therapy, Combination; Ethanolamines; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1983 |
[Use of isosorbide dinitrate in pearl form in the treatment of congestive heart failure. Phonomecanographic study].
Topics: Administration, Oral; Adult; Clinical Trials as Topic; Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Phonocardiography | 1980 |
Effect of isosorbide dinitrate on submaximal exercise capacity of patients with chronic left ventricular failure.
Topics: Double-Blind Method; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Middle Aged; Oxygen Consumption; Physical Exertion; Random Allocation | 1982 |
Circulatory improvement after hydralazine or isosorbide dinitrate administration in patients with heart failure. Effect on metabolic responses to submaximal exercise.
Topics: Adult; Aged; Cardiac Output; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Lactates; Male; Middle Aged; Oxygen Consumption; Physical Exertion | 1981 |
[Treatment of congestive cardiac failure with vasodilators (author's transl)].
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Dihydralazine; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Prazosin; Pulmonary Artery; Vascular Resistance; Vasodilator Agents | 1981 |
Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure.
Topics: Aged; Double-Blind Method; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Middle Aged; Oxygen Consumption; Physical Exertion; Placebos; Pulmonary Wedge Pressure; Random Allocation | 1980 |
[Orally active vasodilators in the management of chronic treatment-resistant cardiac failure (author's transl)].
Topics: Adult; Aged; Dihydralazine; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Middle Aged; Prazosin; Quinazolines | 1980 |
Failure of "effective" treatment for heart failure to improve normal customary activity.
Topics: Activities of Daily Living; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Deoxyepinephrine; Dopamine Agonists; Exercise Test; Exercise Tolerance; Female; Heart Failure; Humans; Indoles; Isosorbide Dinitrate; Male; Middle Aged; Single-Blind Method; Treatment Failure; Vasodilator Agents | 1995 |
Plasma norepinephrine and mortality.
Topics: Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Norepinephrine; Prognosis; Sympathetic Nervous System; Ventricular Dysfunction, Left | 1995 |
Plasma cyclic guanosine monophosphate in chronic heart failure: hemodynamic and neurohormonal correlations and response to nitrate therapy.
Topics: Administration, Oral; Adult; Aged; Chronic Disease; Cyclic GMP; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Neurotransmitter Agents | 1993 |
Comparison of the hemodynamic responses to molsidomine and isosorbide dinitrate in congestive heart failure.
Topics: Biotransformation; Double-Blind Method; Drug Tolerance; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Middle Aged; Molsidomine; Nitrates; Pulmonary Wedge Pressure | 1994 |
[The benefit of combined therapy with captopril and nitrates in severe congestive heart failure].
Topics: Acute Disease; Administration, Oral; Administration, Sublingual; Captopril; Drug Therapy, Combination; Dyspnea; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Statistics as Topic; Time Factors | 1994 |
Potentiation of isosorbide dinitrate effects with N-acetylcysteine in patients with chronic heart failure.
Topics: Acetylcysteine; Adult; Aged; Atrial Natriuretic Factor; Catecholamines; Chronic Disease; Drug Synergism; Drug Therapy, Combination; Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Renin | 1994 |
Effect of vasodilator therapy on mortality in chronic congestive heart failure.
Topics: Adult; Aged; Captopril; Chi-Square Distribution; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Vasodilation; Vasodilator Agents | 1993 |
The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group.
Topics: Atrial Fibrillation; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Morbidity; Prazosin; Prognosis; Risk Factors | 1993 |
The Vasodilator-Heart Failure Trials (V-HeFT). Mechanistic data from the VA Cooperative Studies. Introduction.
Topics: Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Prazosin; Research Design; Survival Analysis; Vasodilator Agents | 1993 |
Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group.
Topics: Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prazosin; Prognosis; Stroke Volume; Survival Analysis; Ventricular Function, Left | 1993 |
Influence of age on mechanisms and prognosis of heart failure. The V-HeFT VA Cooperative Studies Group.
Topics: Age Factors; Aged; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prazosin; Prognosis; Survival Analysis | 1993 |
Influence of prerandomization (baseline) variables on mortality and on the reduction of mortality by enalapril. Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V-HeFT II). V-HeFT VA Cooperative Studies Group.
Topics: Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Risk Factors; Survival Analysis | 1993 |
Mechanism of death in heart failure. The Vasodilator-Heart Failure Trials. The V-HeFT VA Cooperative Studies Group.
Topics: Cause of Death; Death, Sudden, Cardiac; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prazosin; Risk Factors; Survival Analysis | 1993 |
Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. The V-HeFT II VA Cooperative Studies Group.
Topics: Death, Sudden, Cardiac; Drug Therapy, Combination; Electrocardiography, Ambulatory; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prevalence; Risk Factors; Tachycardia, Ventricular | 1993 |
Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group.
Topics: Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Norepinephrine; Renin; Risk Factors; Survival Analysis | 1993 |
Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group.
Topics: Arrhythmias, Cardiac; Cardiomegaly; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Norepinephrine; Oxygen Consumption; Prazosin; Prognosis; Stroke Volume; Ventricular Function, Left | 1993 |
Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure. Results from V-HeFT I and V-HeFT II. The V-HeFT VA Cooperative Studies Group.
Topics: Anaerobic Threshold; Drug Therapy, Combination; Enalapril; Exercise Test; Exercise Tolerance; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prazosin | 1993 |
Echocardiographic variables as prognostic indicators and therapeutic monitors in chronic congestive heart failure. Veterans Affairs cooperative studies V-HeFT I and II. V-HeFT VA Cooperative Studies Group.
Topics: Drug Therapy, Combination; Echocardiography; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prazosin; Survival Analysis; Ventricular Function, Left | 1993 |
Evaluation by patients with heart failure of the effects of enalapril compared with hydralazine plus isosorbide dinitrate on quality of life. V-HeFT II. The V-HeFT VA Cooperative Studies Group.
Topics: Attitude to Health; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Quality of Life; Surveys and Questionnaires | 1993 |
Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA Cooperative Studies Group.
Topics: Drug Therapy, Combination; Enalapril; Heart Failure; Hospitalization; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prazosin; Risk Factors; Time Factors | 1993 |
Incidence of thromboembolic events in congestive heart failure. The V-HeFT VA Cooperative Studies Group.
Topics: Cerebrovascular Disorders; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Incidence; Isosorbide Dinitrate; Male; Middle Aged; Platelet Aggregation Inhibitors; Prazosin; Thromboembolism; Warfarin | 1993 |
[Clinical evaluation of the changes produced by nitrates in patients with chronic heart insufficiency].
Topics: Adult; Aged; Chronic Disease; Double-Blind Method; Echocardiography; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Vasodilator Agents | 1993 |
Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT)
Topics: Aged; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Middle Aged; Prognosis; Stroke Volume; Systole; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Left | 1996 |
Long-term nitrate treatment increases cardiac events in patients with healed myocardial infarction. Secondary Prevention Group.
Topics: Aged; Death, Sudden, Cardiac; Double-Blind Method; Drug Tolerance; Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nitrates; Nitroglycerin; Odds Ratio; Recurrence; Time Factors; Vasodilator Agents | 1996 |
Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Blood-Air Barrier; Bradykinin; Cyclooxygenase Inhibitors; Diffusion; Double-Blind Method; Enalapril; Epoprostenol; Exercise Test; Female; Heart Failure; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Male; Middle Aged; Peptidyl-Dipeptidase A; Pulmonary Alveoli; Pulmonary Circulation; Pulmonary Gas Exchange; Respiratory Function Tests | 1997 |
[Efficacy of mononitrate retard therapy in patients with advanced congestive heart failure].
Topics: Aged; Echocardiography; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Vasodilator Agents | 1997 |
Infusions with molsidomine and isosorbide-5-mononitrate in congestive heart failure: mechanisms underlying attenuation of effects.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Double-Blind Method; Drug Tolerance; Female; Fluid Shifts; Heart Atria; Heart Failure; Heart Rate; Hematocrit; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Molsidomine; Neurotransmitter Agents; Pulmonary Artery; Renin; Time Factors; Vascular Resistance; Vasodilator Agents; Ventricular Function, Left | 1998 |
Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema.
Topics: Acute Disease; Aged; Diuretics; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; Incidence; Injections, Intravenous; Isosorbide Dinitrate; Male; Myocardial Infarction; Prospective Studies; Pulmonary Edema; Respiration, Artificial; Treatment Outcome; Vasodilator Agents | 1998 |
[Effect of trekrezan on the lipid peroxidation in patients with chronic cardiac insufficiency].
Topics: Acetates; Adjuvants, Immunologic; Adult; Aged; Chronic Disease; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Heart Failure; Humans; Isosorbide Dinitrate; Lipid Peroxidation; Male; Middle Aged; Vasodilator Agents | 1998 |
Effects of high-dose lisinopril-isosorbide dinitrate on severe mitral regurgitation and heart failure remodeling.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Lisinopril; Male; Middle Aged; Mitral Valve Insufficiency; Severity of Illness Index; Ultrasonography; Vasodilator Agents; Ventricular Remodeling | 1998 |
The impact of beta-receptor blocker addition to high-dose angiotensin-converting enzyme inhibitor-nitrate therapy in heart failure.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Cohort Studies; Drug Therapy, Combination; Echocardiography, Doppler; Female; Heart Failure; Humans; Isosorbide Dinitrate; Lisinopril; Male; Middle Aged; Prospective Studies; Retrospective Studies; Treatment Outcome; Vasodilator Agents | 1998 |
Effect of inhaled nitric oxide on gas exchange in patients with congestive heart failure. A randomized, controlled trial.
Topics: Administration, Inhalation; Adult; Aged; Carbon Dioxide; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Isosorbide Dinitrate; Male; Middle Aged; Nitric Oxide; Oxygen; Pulmonary Gas Exchange; Vasodilator Agents | 1999 |
Effect of isosorbide-5-mononitrate on exercise performance and clinical status in patients with congestive heart failure. Results of the Nitrates in Congestive Heart Failure (NICE) Study.
Topics: Administration, Oral; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diuretics; Double-Blind Method; Electrocardiography; Exercise Test; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Quality of Life; Vasodilator Agents | 1999 |
Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group.
Topics: Angiotensin-Converting Enzyme Inhibitors; Black People; Double-Blind Method; Drug Therapy, Combination; Enalapril; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Norepinephrine; Renin; Retrospective Studies; Survival Rate; Treatment Outcome; Vasodilator Agents; White People | 1999 |
[Functional activity of platelet guanylate cyclase and cardiac hemodynamics in patients with chronic heart failure and relevant changes after treatment with isosorbide-5-mononitrate].
Topics: Administration, Oral; Aged; Biomarkers; Blood Platelets; Delayed-Action Preparations; Electrocardiography; Endothelium, Vascular; Exercise Tolerance; Follow-Up Studies; Guanylate Cyclase; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitric Oxide Synthase; Treatment Outcome; Vasodilator Agents | 1999 |
Effects of chronic nitrate therapy on left-ventricular volume in patients with heart failure secondary to coronary disease already treated with captopril: a withdrawal study.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Coronary Disease; Diuretics; Double-Blind Method; Heart Failure; Humans; Isosorbide Dinitrate; Middle Aged; Myocardial Infarction; Substance Withdrawal Syndrome; Vasodilator Agents | 2001 |
A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
Topics: Analysis of Variance; Digoxin; Diltiazem; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Electrolytes; Enzyme Inhibitors; Female; Half-Life; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Ischemia; Vasodilator Agents | 2002 |
Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Cardiac Catheterization; Cardiac Output; Chronic Disease; Clinical Trials as Topic; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Vascular Resistance; Vasodilator Agents | 1977 |
Orally administered isosorbide dinitrate in patients with and without left ventricular failure due to acute myocardial infarction.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Cardiac Catheterization; Cardiac Output; Clinical Trials as Topic; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction | 1977 |
Nitrate therapy for congestive heart failure.
Topics: Adult; Aged; Clinical Trials as Topic; Coronary Disease; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Time Factors | 1978 |
Comparative haemodynamic and peripheral vasodilator effects of oral and chewable isosorbide dinitrate in patients with refractory congestive cardiac failure.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Leg; Male; Middle Aged; Regional Blood Flow; Stroke Volume; Vascular Resistance; Vasodilation | 1979 |
Cardiocirculatory effects of nitrates in the treatment of clinical congestive heart failure.
Topics: Blood Pressure; Cardiac Output; Clinical Trials as Topic; Ferricyanides; Heart Failure; Heart Rate; Hemodynamics; Humans; Isosorbide Dinitrate; Myocardial Contraction; Nitroprusside; Phentolamine; Placebos; Vascular Resistance | 1978 |
Is the use of long acting nitrates beneficial in the patient with angina pectoris? (The positive side).
Topics: Administration, Oral; Angina Pectoris; Biological Availability; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Drug Stability; Electrocardiography; Heart Failure; Heart Rate; Humans; Isosorbide Dinitrate; Kinetocardiography; Myocardial Contraction; Nitrates; Nitroglycerin; Ointments; Oxygen Consumption; Vascular Resistance | 1977 |
Immediate effects of hydralazine-isosorbide dinitrate combination on exercise capacity and exercise hemodynamics in patients with left ventricular failure.
Topics: Adult; Aged; Drug Therapy, Combination; Exercise Test; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Middle Aged | 1979 |
Comparative hemodynamic effects of chewable isosorbide dinitrate and nitroglycerin in patients with congestive heart failure.
Topics: Administration, Oral; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Delayed-Action Preparations; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Mouth Floor; Nitroglycerin; Placebos | 1975 |
[Efficacy of a new slow-release isosorbide dinitrate preparation in myocardial infarction (author's transl)].
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Delayed-Action Preparations; Electrocardiography; Female; Heart Failure; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Placebos | 1975 |
Modulation of inotropic therapy by venodilation in acute heart failure: a randomised comparison of four inotropic agents, alone and combined with isosorbide dinitrate.
Topics: Adult; Aged; Amrinone; Cardiotonic Agents; Digoxin; Dobutamine; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Prenalterol; Prospective Studies; Single-Blind Method; Vasodilation | 1992 |
[Effects of peripheral vasodilators on arrhythmia in patients with chronic coronary insufficiency].
Topics: Arrhythmias, Cardiac; Captopril; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Nitroglycerin; Vasodilator Agents | 1992 |
[Results of conventional treatment of severe congestive heart failure with vasodilators].
Topics: Adult; Aged; Captopril; Digoxin; Drug Administration Schedule; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Time Factors; Vasodilator Agents | 1992 |
Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial.
Topics: Actuarial Analysis; Captopril; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Time Factors | 1992 |
V-HeFT positive for enalapril.
Topics: Adolescent; Adult; Aged; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged | 1991 |
Randomized study to evaluate the relation between oral isosorbide dinitrate dosing interval and the development of early tolerance to its effect on left ventricular filling pressure in patients with chronic heart failure.
Topics: Drug Administration Schedule; Drug Tolerance; Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Prospective Studies; Pulmonary Wedge Pressure; Time Factors; Ventricular Function, Left | 1991 |
Studies of Left Ventricular Dysfunction (SOLVD)--new hope for heart failure.
Topics: Drug Therapy, Combination; Enalapril; Heart Failure; Hospitalization; Humans; Hydralazine; Isosorbide Dinitrate; Stroke Volume; Survival Rate | 1991 |
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.
Topics: Adolescent; Adult; Aged; Chronic Disease; Death, Sudden; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Enalapril; Heart Failure; Hospitalization; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Norepinephrine; Oxygen Consumption; Patient Compliance; Physical Exertion; Stroke Volume; Survival Rate | 1991 |
Comparative evaluation of a new formulation of isosorbide dinitrate oral spray and sublingual nitroglycerin tablets.
Topics: Administration, Oral; Administration, Sublingual; Aerosols; Chemistry, Pharmaceutical; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Randomized Controlled Trials as Topic; Tablets; Time Factors | 1990 |
[Long-term nitrate therapy in coronary heart disease--loss of effect by developing tolerance].
Topics: Angina Pectoris; Coronary Disease; Dose-Response Relationship, Drug; Drug Tolerance; Electrocardiography; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Long-Term Care; Male; Middle Aged; Nitroglycerin; Pentaerythritol Tetranitrate | 1990 |
A dose-finding study of the hemodynamic effect of isosorbide dinitrate spray in congestive heart failure.
Topics: Administration, Oral; Adult; Aerosols; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Randomized Controlled Trials as Topic | 1990 |
A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure.
Topics: Adolescent; Adult; Aged; Blood Pressure; Chronic Disease; Diuretics; Double-Blind Method; Drug Combinations; Exercise Test; Female; Heart Failure; Heart Rate; Hospitalization; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardium; Nifedipine; Oxygen Consumption; Time Factors | 1990 |
Statistical significance of Veterans Administration Vasodilator Heart Failure Trial results.
Topics: Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Prazosin; Research Design; Statistics as Topic; United States; United States Department of Veterans Affairs | 1990 |
Haemodynamic comparison of different routes of nitrate administration in postmyocardial infarction left ventricular failure.
Topics: Administration, Buccal; Administration, Cutaneous; Adult; Aged; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Randomized Controlled Trials as Topic | 1989 |
[Long-term effect of various nitrates in ischemic heart disease and latent heart failure].
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Electrocardiography; Exercise Test; Female; Heart Failure; Humans; Isosorbide Dinitrate; Long-Term Care; Male; Middle Aged; Myocardial Infarction; Pentaerythritol Tetranitrate; Propylene Glycols; Pulmonary Wedge Pressure; Randomized Controlled Trials as Topic; Vasodilator Agents | 1989 |
[Afterload reduction by long-term nitrate therapy].
Topics: Blood Pressure; Clinical Trials as Topic; Delayed-Action Preparations; Drug Administration Schedule; Drug Tolerance; Exercise Test; Heart Failure; Humans; Isosorbide Dinitrate; Long-Term Care; Vascular Resistance | 1989 |
[Development and status of nitrate therapy in East Germany].
Topics: Angina Pectoris; Delayed-Action Preparations; Dose-Response Relationship, Drug; Germany, East; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Myocardial Infarction; Nitrates; Nitroglycerin; Pentaerythritol Tetranitrate; Propylene Glycols; Vasodilator Agents | 1989 |
[Hemodynamic effect of subchronic therapy with 120 mg isosorbide dinitrate in a slow release form in minimal to moderate post-infarct heart failure].
Topics: Aged; Clinical Trials as Topic; Delayed-Action Preparations; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction | 1989 |
Comparison of the immediate and long-term effects of captopril and isosorbide dinitrate as adjunctive treatment in mild heart failure.
Topics: Blood Pressure; Captopril; Digoxin; Diuretics; Exercise Test; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Renin; Time Factors | 1989 |
Heart failure management: the impact of drug therapy on survival.
Topics: Captopril; Clinical Trials as Topic; Digitalis Glycosides; Diuretics; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Time Factors | 1988 |
Role of vasodilators in the treatment of congestive heart failure.
Topics: Captopril; Clinical Trials as Topic; Dipeptides; Double-Blind Method; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Prazosin; Random Allocation; Regional Blood Flow; Vascular Resistance; Vasodilator Agents | 1985 |
Effect of vasodilator therapy on mortality in chronic congestive heart failure.
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Prazosin; Random Allocation | 1988 |
Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Exercise Test; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prazosin; Random Allocation; Vasodilator Agents | 1986 |
Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prazosin; Prognosis; Random Allocation | 1987 |
A comparison of intravenous elantan and frusemide in patients with chronic cardiac failure.
Topics: Blood Pressure; Cardiac Output; Chronic Disease; Coronary Circulation; Furosemide; Heart Failure; Humans; Injections, Intravenous; Isosorbide Dinitrate | 1987 |
Calcium channel blocker and isosorbide 5-mononitrate in the management of chronic cardiac failure.
Topics: Chronic Disease; Coronary Disease; Drug Therapy, Combination; Exercise Test; Felodipine; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Middle Aged; Nitrendipine | 1987 |
Comparative effects of captopril and isosorbide dinitrate on pulmonary arteriolar resistance and right ventricular function in patients with severe left ventricular failure: results of a randomized crossover study.
Topics: Captopril; Clinical Trials as Topic; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Hypotension; Isosorbide Dinitrate; Proline; Pulmonary Circulation; Vascular Resistance | 1985 |
[Vasodilator effects of intravenous isosorbide dinitrate in patients with heart failure--multi-center studies].
Topics: Clinical Trials as Topic; Drug Evaluation; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Isosorbide Dinitrate | 1985 |
Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Cardiac Catheterization; Cardiac Output; Clinical Trials as Topic; Heart Failure; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Placebos; Pressure; Time Factors | 1974 |
295 other study(ies) available for isosorbide dinitrate and Heart Failure
| Article | Year |
|---|---|
Cardiologists' Perspectives on BiDil and the Use of Race in Drug Prescribing.
Topics: Cardiologists; Cross-Sectional Studies; Drug Prescriptions; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate | 2022 |
When the Whole Is the Sum of Its Parts: Validation of the Heart Failure Collaboratory Medication Composite Score in Denmark.
Topics: Denmark; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate | 2023 |
High-dose nitrate therapy recovers the expression of subtypes α
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Disease Models, Animal; Drug Therapy, Combination; Heart Failure; Imidazoles; Isosorbide Dinitrate; Kidney Cortex; Male; Myocardial Infarction; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Time Factors | 2020 |
Captopril Versus Hydralazine-Isosorbide Dinitrate Vasodilator Protocols in Patients With Acute Decompensated Heart Failure Transitioning From Sodium Nitroprusside.
Topics: Adult; Aftercare; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitroprusside; Patient Discharge; Retrospective Studies; Vasodilator Agents | 2021 |
Vericiguat, organic nitrates, and heart failure in African Americans.
Topics: Black or African American; Heart Failure; Heterocyclic Compounds, 2-Ring; Humans; Hydralazine; Isosorbide Dinitrate; Nitrates; Pyrimidines; Stroke Volume | 2021 |
The effect of intravenous isosorbide dinitrate in acute decompensated heart failure in hospital.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Case-Control Studies; Female; France; Heart Failure; Hospital Mortality; Hospitalization; Humans; Isosorbide Dinitrate; Male; Myocardial Infarction; Patient Readmission; Pilot Projects; Retrospective Studies; Treatment Outcome; Vasodilator Agents | 2017 |
Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride: Retrospective Propensity-Matched Analysis in Black Medicare Patients with Heart Failure.
Topics: Adult; Black or African American; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Kaplan-Meier Estimate; Male; Medicare; Middle Aged; Off-Label Use; Prospective Studies; Retrospective Studies; United States | 2017 |
Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate in African-American Patients With Heart Failure.
Topics: Adult; Aged; Black or African American; Cardiotonic Agents; Drug Combinations; Female; Heart Failure; Humans; Hydralazine; Incidence; Isosorbide Dinitrate; Male; Middle Aged; Treatment Outcome; United States; Young Adult | 2017 |
The Paradox in Demonstrating Hydralazine-Nitrate Efficacy.
Topics: Black or African American; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Treatment Outcome | 2017 |
Adherence to the evidence-based heart failure drug treatment: Are there sex-specific differences among new users?
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Drug Combinations; Evidence-Based Medicine; Female; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Medication Adherence; Middle Aged; Sex Factors; Young Adult | 2018 |
[Analysis of the mitochondrial function and ultrastructure in healthy albino mice treated with heart failure medications]
Topics: Animals; Antihypertensive Agents; Atenolol; Cardiotonic Agents; Digoxin; Disease Models, Animal; Diuretics; Electrocardiography; Enalapril; Female; Furosemide; Heart Failure; Isosorbide Dinitrate; Male; Mice; Mitochondria, Heart; Spironolactone | 2017 |
Underuse of hydralazine and isosorbide dinitrate for heart failure in patients of African ancestry: a cross-European survey.
Topics: Black People; Cardiovascular Agents; Cross-Sectional Studies; Databases, Pharmaceutical; Drug Combinations; Drug Prescriptions; Europe; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate | 2019 |
Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction.
Topics: Aged; Aged, 80 and over; Black or African American; Chi-Square Distribution; Drug Combinations; Drug Utilization Review; Female; Guideline Adherence; Healthcare Disparities; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prospective Studies; Registries; Stroke Volume; Time Factors; Treatment Outcome; United States; Vasodilator Agents; Ventricular Function, Left | 2013 |
Genetic mechanisms possibly leading to racially different responses to nitrate therapy.
Topics: Black or African American; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate | 2014 |
Current perspectives on hydralazine and nitrate therapies in heart failure.
Topics: Age Factors; Drug Combinations; Female; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Randomized Controlled Trials as Topic; Sex Factors | 2014 |
Polymorphic variation in the G-protein beta-3 subunit gene and response to BiDil in A-HeFT: Basis for an African-American pharmacogenetic advantage to nitric oxide donor therapy?
Topics: Female; Heart Failure; Heterotrimeric GTP-Binding Proteins; Humans; Hydralazine; Isosorbide Dinitrate; Male; Polymorphism, Single Nucleotide; Vasodilator Agents | 2014 |
Heart failure: Nitrates reduce activity levels in HFpEF.
Topics: Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Vasodilator Agents | 2016 |
Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Get With The Guidelines-Heart Failure Registry.
Topics: Aged; Aged, 80 and over; Chi-Square Distribution; Disease Progression; Drug Combinations; Female; Guideline Adherence; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Kaplan-Meier Estimate; Logistic Models; Male; Medicare Part D; Patient Discharge; Patient Readmission; Practice Guidelines as Topic; Practice Patterns, Physicians'; Proportional Hazards Models; Registries; Risk Factors; Stroke Volume; Time Factors; Treatment Outcome; United States | 2016 |
Making Medicine Precise and Personalized: What Can We Learn from the Past?
Topics: Female; Guideline Adherence; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Practice Guidelines as Topic; Practice Patterns, Physicians'; Stroke Volume | 2016 |
PGX: Pharmacogenomics During Generation X.
Topics: Anticoagulants; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Pharmaceutical Preparations; Pharmacogenetics; Pharmacogenomic Variants; Pharmacokinetics; Precision Medicine; Pulmonary Embolism; Renal Insufficiency, Chronic; Stroke | 2016 |
Nitrates in Heart Failure with Preserved Ejection Fraction.
Topics: Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Vasodilator Agents | 2016 |
Nitrates in Heart Failure with Preserved Ejection Fraction.
Topics: Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Vasodilator Agents | 2016 |
Nitrates in Heart Failure with Preserved Ejection Fraction.
Topics: Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Vasodilator Agents | 2016 |
Nitrates in Heart Failure with Preserved Ejection Fraction.
Topics: Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Vasodilator Agents | 2016 |
Dilemmas With Race and Heart Failure Treatment.
Topics: Black or African American; Clinical Decision-Making; Drug Combinations; Health Status Disparities; Healthcare Disparities; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Patient Selection; Treatment Outcome; United States; Vasodilator Agents | 2016 |
Effect of Oral Nitrates on All-Cause Mortality and Hospitalization in Heart Failure Patients with Reduced Ejection Fraction: A Propensity-Matched Analysis.
Topics: Aged; Cardiovascular Agents; Female; Heart Failure; Hospitalization; Humans; Isosorbide Dinitrate; Male; Middle Aged; Mortality; Propensity Score; Retrospective Studies; Risk Factors; Stroke Volume; Survival Analysis; Turkey; Ventricular Dysfunction, Left | 2017 |
Introduction: Facts and fictions: BiDil and the resurgence of racial medicine.
Topics: Black People; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Vasodilator Agents | 2008 |
Flaws in the U.S. Food and Drug Administration's rationale for supporting the development and approval of BiDil as a treatment for heart failure only in black patients.
Topics: Black People; Drug Approval; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; United States; United States Food and Drug Administration; Vasodilator Agents | 2008 |
Popular representations of race: the news coverage of BiDil.
Topics: Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Mass Media; Racial Groups; Vasodilator Agents | 2008 |
"Special treatment": BiDil, Tuskegee, and the logic of race.
Topics: Black or African American; Clinical Trials as Topic; Drug Approval; Drug Combinations; Ethics, Medical; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Prejudice; Racial Groups; Syphilis; Vasodilator Agents; Withholding Treatment | 2008 |
Exploring the potential synergistic action of spironolactone on nitric oxide-enhancing therapy: insights from the African-American Heart Failure Trial.
Topics: Adult; Aged; Black or African American; Clinical Trials, Phase III as Topic; Drug Combinations; Drug Synergism; Female; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Multicenter Studies as Topic; Nitric Oxide Donors; Randomized Controlled Trials as Topic; Retrospective Studies; Spironolactone | 2008 |
From the editors.
Topics: Analgesia; Bioethical Issues; Bioethics; Black or African American; Conscience; Drug Combinations; Ethics, Clinical; Heart Failure; Humans; Hydralazine; Interdisciplinary Communication; Isosorbide Dinitrate; Liver Diseases, Alcoholic; Liver Transplantation; Morals; Neurosciences; Patient-Centered Care; Persistent Vegetative State; Social Sciences; United States; United States Food and Drug Administration; Waiting Lists | 2009 |
Race-based medicine and justice as recognition: exploring the phenomenon of BiDil.
Topics: Black or African American; Cardiovascular Agents; Drug Approval; Drug Combinations; Drug Design; Ethical Theory; Healthcare Disparities; Heart Failure; History, 20th Century; History, 21st Century; Humans; Hydralazine; Isosorbide Dinitrate; Social Justice; United States | 2009 |
Pharmacogenetics, race and global injustice.
Topics: Black or African American; Delivery of Health Care; Developing Countries; Drug Combinations; Heart Failure; Humans; Hydralazine; Internationality; Isosorbide Dinitrate; Pharmacogenetics; Racial Groups; Social Justice; United States; United States Food and Drug Administration | 2008 |
Combined use of PDE5 inhibitors and nitrates in the treatment of pulmonary arterial hypertension in patients with heart failure.
Topics: Cyclic GMP; Drug Therapy, Combination; Heart Failure; Humans; Hypertension, Pulmonary; Isosorbide Dinitrate; Male; Middle Aged; Nitro Compounds; Nitroglycerin; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Pulmonary Artery; Purines; Sildenafil Citrate; Sulfones; Vasodilation; Vasodilator Agents | 2009 |
Isosorbide dinitrate/hydralazine: its role in the treatment of heart failure.
Topics: Animals; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Interactions; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Pregnancy; Vasodilator Agents; Ventricular Dysfunction, Left | 2008 |
Usefulness of Isosorbide Dinitrate and Hydralazine as add-on therapy in patients discharged for advanced decompensated heart failure.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Female; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged | 2009 |
Have we witnessed the rise and fall of race-specific drugs?
Topics: Black or African American; Drug Combinations; Heart Failure; Hispanic or Latino; Humans; Hydralazine; Isosorbide Dinitrate; Patient Selection; Risk Assessment; Risk Factors; Treatment Outcome; Vasodilator Agents; White People | 2009 |
Effectiveness of hydralazine/isosorbide dinitrate in racial/ethnic subgroups with heart failure.
Topics: Aged; Black or African American; Drug Combinations; Drug Prescriptions; Female; Heart Failure; Hispanic or Latino; Hospitalization; Humans; Hydralazine; Isosorbide Dinitrate; Male; Patient Selection; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; United States; Vasodilator Agents; Veterans; White People | 2009 |
Effects of fixed-dose isosorbide dinitrate/hydralazine on diastolic function and exercise capacity in hypertension-induced diastolic heart failure.
Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Blood Pressure; Cytokines; Diastole; Drug Therapy, Combination; Echocardiography, Doppler; Exercise Test; Fibrosis; Gene Expression; Heart; Heart Failure; Hydralazine; Hypertension; Isosorbide Dinitrate; Male; Mice; Myocardium; Reverse Transcriptase Polymerase Chain Reaction; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sodium Chloride, Dietary; Vascular Cell Adhesion Molecule-1; Vasodilator Agents | 2009 |
Primary care physicians' attitudes regarding race-based therapies.
Topics: Adult; Aged; Attitude of Health Personnel; Black People; Drug Combinations; Female; Focus Groups; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Physician-Patient Relations; Physicians, Primary Care; Racial Groups; White People | 2010 |
Isosorbide dinitrate and hydralazine as therapy for African Americans with heart failure; a failed paradigm?
Topics: Black or African American; Cardiology; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Models, Theoretical; Polymorphism, Genetic; Translational Research, Biomedical; Treatment Outcome | 2009 |
Grassroots marketing in a global era: more lessons from BiDil.
Topics: Black People; Drug Combinations; Drug Industry; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Marketing; Pharmacogenetics | 2011 |
Comparison of nitrite compounds and carperitide for initial treatment of acute decompensated heart failure.
Topics: Aged; Aged, 80 and over; Atrial Natriuretic Factor; Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Treatment Outcome | 2011 |
Letter by Taylor et al regarding article, "Hydralazine and isosorbide dinitrate in heart failure: historical perspectives, mechanisms, and future directions".
Topics: Animals; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate | 2011 |
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Data Interpretation, Statistical; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prognosis; Randomized Controlled Trials as Topic; Survival Analysis; Weight Loss | 2003 |
Effects of a nitro compound patch on neuropathy in Churg-Strauss syndrome.
Topics: Adrenergic beta-Agonists; Asthma; Churg-Strauss Syndrome; Cyclophosphamide; Drug Hypersensitivity; Female; Heart Failure; Humans; Immunosuppressive Agents; Isosorbide Dinitrate; Middle Aged; Nitric Oxide Donors; Nitro Compounds; Nitroglycerin; Peroneal Neuropathies; Pulmonary Eosinophilia; Terbutaline; Theophylline; Vasodilator Agents | 2003 |
Getting the numbers right: statistical mischief and racial profiling in heart failure research.
Topics: Adult; Aged; Black or African American; Clinical Trials as Topic; Data Interpretation, Statistical; Drug Combinations; Epidemiologic Research Design; Female; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prejudice; Socioeconomic Factors; United States; White People | 2003 |
[Not just effective against symptoms of ischemia. Nitrates also improve prognosis].
Topics: Aged; Coronary Disease; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Nitroglycerin; Prognosis; Vasodilator Agents | 2002 |
Race-based therapeutics.
Topics: Angiotensin-Converting Enzyme Inhibitors; Black People; Drug Approval; Drug Combinations; Drug Industry; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitric Oxide Donors; Patents as Topic; Pharmacogenetics; United States; United States Food and Drug Administration; Vasodilator Agents | 2004 |
Nitroso-redox balance in the cardiovascular system.
Topics: Black People; Cardiovascular System; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Oxidation-Reduction; Signal Transduction; Superoxides; Vasodilator Agents | 2004 |
Postcards: race and medicine in the 21st century.
Topics: Black or African American; Clinical Trials as Topic; Drug Approval; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; United States | 2004 |
Color blind.
Topics: Black or African American; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Prejudice; Racial Groups; Therapeutics | 2004 |
Studying treatment of heart failure in blacks.
Topics: Black People; Drug Therapy, Combination; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Marketing; Prevalence; Research Design; United States | 2005 |
A cure for a race? Heart drug findings set off ethics debate.
Topics: Black or African American; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Drugs, Investigational; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Marketing of Health Services; Pharmacogenetics; Racial Groups; Treatment Outcome; United States | 2004 |
The year in heart failure: 2004.
Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Defibrillators, Implantable; Disease Management; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Monitoring, Physiologic; Prognosis; Treatment Outcome; Vasodilator Agents; Ventricular Remodeling | 2005 |
Isosorbide dinitrate and hydralazine in blacks with heart failure.
Topics: Black People; Coronary Disease; Drug Therapy, Combination; Heart Failure; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Vasodilator Agents | 2005 |
Isosorbide dinitrate and hydralazine in blacks with heart failure.
Topics: Black People; Drug Therapy, Combination; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Lupus Erythematosus, Systemic; Vasodilator Agents | 2005 |
Isosorbide dinitrate and hydralazine in blacks with heart failure.
Topics: Black People; Data Interpretation, Statistical; Drug Therapy, Combination; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Vasodilator Agents | 2005 |
Isosorbide dinitrate and hydralazine in blacks with heart failure.
Topics: Black People; Calcium Channel Blockers; Drug Therapy, Combination; Heart Failure; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Vasodilator Agents | 2005 |
Race and a heart drug.
Topics: Black People; Drug Therapy, Combination; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Multicenter Studies as Topic; Nitric Oxide; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome; Vasodilator Agents; White People | 2005 |
U.S. to review drug intended for one race.
Topics: Black or African American; Cardiovascular Agents; Clinical Trials as Topic; Drug Approval; Drug Combinations; Drug Industry; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Marketing of Health Services; Pharmacogenetics; Racial Groups; United States; United States Food and Drug Administration | 2005 |
Drug targeting: is race enough?
Topics: Asian People; Black or African American; Drug Combinations; Drug Industry; ErbB Receptors; Gefitinib; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Pharmacogenetics; Quinazolines; United States; United States Food and Drug Administration | 2005 |
Pharmacogenetics and ethnically targeted therapies: racial drugs need to be put in context.
Topics: Conflict of Interest; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Pharmacogenetics; Racial Groups | 2005 |
F.D.A. panel approves heart remedy for blacks.
Topics: Advisory Committees; Black or African American; Drug Approval; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; United States; United States Food and Drug Administration | 2005 |
F.D.A. approves a heart drug for African-Americans.
Topics: Black or African American; Drug Approval; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; United States; United States Food and Drug Administration | 2005 |
Misreading race and genomics after BiDil.
Topics: Black or African American; Cardiovascular Agents; Drug Approval; Drug Combinations; Genomics; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; United States; United States Food and Drug Administration | 2005 |
Race, drugs, and heart failure.
Topics: Aged; Aged, 80 and over; Black People; Drug Combinations; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome; United States; Vasodilator Agents | 2005 |
Color blind, or just plain blind?
Topics: Arginine; Black People; Delayed-Action Preparations; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitric Oxide; Pharmacogenetics; Vasodilator Agents | 2005 |
Maker of heart drug intended for blacks bases price on patients' wealth.
Topics: Black or African American; Costs and Cost Analysis; Drug Combinations; Drug Costs; Drug Industry; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Marketing; Socioeconomic Factors; United States | 2005 |
Illuminating BiDil.
Topics: Black or African American; Drug Approval; Drug Combinations; Genetic Predisposition to Disease; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Politics; Public Policy; United States | 2005 |
New heart-failure therapy takes race into account.
Topics: Black People; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Female; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Quality of Life; Surveys and Questionnaires; Treatment Outcome | 2005 |
Drug success signals a new trend. A "race-based" medication is a step toward individualized care.
Topics: Black People; Clinical Trials as Topic; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitric Oxide; Vasodilator Agents | 2005 |
Drugs tailored to race move a step closer to reality.
Topics: Black or African American; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Pharmacogenetics | 2005 |
BiDil for heart failure.
Topics: Adjuvants, Pharmaceutic; Administration, Oral; Black People; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Vasodilator Agents | 2005 |
Race as a proxy for drug response: the dangers and challenges of ethnic drugs.
Topics: Black or African American; Clinical Trials as Topic; Commerce; Conflict of Interest; Drug Combinations; Drug Industry; Ethnicity; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Pharmacogenetics; Racial Groups | 2004 |
Update on outpatient treatment of systolic heart failure.
Topics: Ambulatory Care; Black or African American; Diuretics; Drug Therapy, Combination; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Spironolactone; Treatment Outcome; Vasodilator Agents | 2005 |
Approval of drug marketed to African Americans raises political, economic issues. Study criticizes manufacturer for re-branding generic drug with race-specific indication.
Topics: Black or African American; Drug Approval; Drug Combinations; Drug Industry; Economics; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Marketing; Politics; United States; United States Food and Drug Administration | 2005 |
BiDil's impact.
Topics: Black or African American; Drug Approval; Drug Combinations; Genetic Predisposition to Disease; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Risk; United States | 2005 |
Cost-effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine therapy for blacks with heart failure.
Topics: Black People; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Female; Health Care Costs; Heart Failure; Hospitalization; Humans; Hydralazine; Isosorbide Dinitrate; Length of Stay; Male; Middle Aged; Randomized Controlled Trials as Topic; Retrospective Studies | 2005 |
Gray area for new heart failure drug. Although the FDA approved BiDil for blacks with heart failure, it may work in anyone.
Topics: Black People; Drug Approval; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitric Oxide; Pharmacogenetics; Racial Groups | 2005 |
A look back at the most influential drug approvals of 2005.
Topics: Amyloid; Analgesics; Anticonvulsants; Antiparkinson Agents; Diabetes Mellitus, Type 2; Diphtheria-Tetanus-Pertussis Vaccine; Drug Approval; Drug Combinations; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Exenatide; gamma-Aminobutyric Acid; Heart Failure; Humans; Hydralazine; Hypoglycemic Agents; Indenes; Indoles; Islet Amyloid Polypeptide; Isosorbide Dinitrate; Patient Education as Topic; Patient Selection; Peptides; Pregabalin; Sleep Wake Disorders; United States; United States Food and Drug Administration; Venoms | 2006 |
The isosorbide-hydralazine story: is there a case for race-based cardiovascular medicine?
Topics: Antihypertensive Agents; Black or African American; Diuretics, Osmotic; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitric Oxide Synthase; Risk Assessment; Socioeconomic Factors; United States | 2006 |
"Racially-tailored" medicine unraveled.
Topics: Cardiovascular Agents; Civil Rights; Delivery of Health Care; Drug Combinations; Ethics Committees, Research; Federal Government; Financing, Government; Genetic Research; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; National Institutes of Health (U.S.); Organizational Policy; Patient Rights; Pharmacogenetics; Prejudice; Racial Groups; State Government; United States | 2005 |
Novel heart failure drug may offer options for you.
Topics: Black or African American; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Vasodilator Agents | 2005 |
Food & Drug Administration panel approves heart failure medication aimed at African-Americans.
Topics: Advisory Committees; Black or African American; Drug Approval; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; United States; United States Food and Drug Administration; Vasodilator Agents | 2005 |
Using race in clinical research to develop tailored medications. Is the FDA encouraging discrimination or eliminating traditional disparities in health care for African Americans?
Topics: Black or African American; Clinical Protocols; Clinical Trials as Topic; Drug Approval; Drug Combinations; Drug Industry; Drugs, Investigational; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Patient Selection; Pharmacogenetics; Prejudice; Socioeconomic Factors; Supreme Court Decisions; Treatment Outcome; United States; United States Food and Drug Administration; Vasodilator Agents | 2006 |
Nicorandil but not ISDN upregulates endothelial nitric oxide synthase expression, preventing left ventricular remodeling and degradation of cardiac function in Dahl salt-sensitive hypertensive rats with congestive heart failure.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiac Volume; Heart Failure; Hypertension; Isosorbide Dinitrate; Male; Nicorandil; Nitric Oxide Donors; Nitric Oxide Synthase Type III; Potassium Channels; Rats; Rats, Inbred Dahl; RNA, Messenger; Up-Regulation; Ventricular Remodeling | 2006 |
Prescribing BiDil: is it black and white?
Topics: Angiotensin-Converting Enzyme Inhibitors; Black People; Drug Approval; Drug Combinations; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Treatment Outcome; United States; United States Food and Drug Administration; White People | 2006 |
Diagnosis and management of chronic heart failure.
Topics: Adult; Drug Therapy, Combination; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Practice Guidelines as Topic; Vasodilator Agents | 2006 |
Response to the February 2006 Journal of Cardiac Failure Editor's comment.
Topics: Black or African American; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate | 2006 |
The use of race and ethnicity in medicine: lessons from the African-American Heart Failure Trial.
Topics: Biomedical Research; Black or African American; Civil Rights; Drug Combinations; Ethical Analysis; Evidence-Based Medicine; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Patient Selection; Pharmacogenetics; Prejudice; Randomized Controlled Trials as Topic; United States; Vasodilator Agents | 2006 |
Race, money and medicines.
Topics: Biomedical Research; Civil Rights; Drug Approval; Drug Combinations; Drug Industry; Ethical Analysis; Ethnicity; Health Care Costs; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Patient Selection; Prejudice; Racial Groups; Randomized Controlled Trials as Topic; Sociology, Medical; United States; United States Food and Drug Administration; Vasodilator Agents | 2006 |
BiDil for heart failure in black patients: implications of the U.S. Food and Drug Administration approval.
Topics: Black People; Cardiovascular Agents; Drug Approval; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Public Policy; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration | 2007 |
BiDil for heart failure in black patients: The U.S. Food and Drug Administration perspective.
Topics: Black People; Cardiovascular Agents; Drug Approval; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Public Policy; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration | 2007 |
Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure Trial.
Topics: Adult; Aged; Antihypertensive Agents; Black or African American; Blood Pressure; Comorbidity; Drug Combinations; Female; Heart Failure; Humans; Hydralazine; Hypotension; Isosorbide Dinitrate; Male; Middle Aged; Randomized Controlled Trials as Topic; Systole; Treatment Outcome; Vasodilator Agents | 2007 |
Editorial commentary on fixed combination isosorbide dinitrate/hydralazine for nitric-oxide-enhancing therapy in heart failure.
Topics: Black or African American; Chemistry, Pharmaceutical; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitric Oxide Donors | 2007 |
From disparity to difference: how race-specific medicines may undermine policies to address inequalities in health care.
Topics: Black or African American; Drug Combinations; Ethnicity; Health Policy; Health Services Accessibility; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Pharmacogenetics; Prejudice; Social Justice; Socioeconomic Factors; United States | 2005 |
[Endothelial dysfunction in patients with chronic heart failure, and possibilities of its correction with isosorbide-5-mononitrates].
Topics: Administration, Oral; Aged; Brachial Artery; Delayed-Action Preparations; Disease Progression; Dose-Response Relationship, Drug; Endothelium, Vascular; Exercise Test; Follow-Up Studies; Heart Failure; Humans; Isosorbide Dinitrate; Male; Stroke Volume; Treatment Outcome; Ultrasonography, Doppler; Vasodilation; Vasodilator Agents | 2007 |
Hydralazine and nitrates: beyond race and ethnicity.
Topics: Cardiotonic Agents; Drug Combinations; Heart Failure; Humans; Isosorbide Dinitrate; Milrinone; Racial Groups; Research Design; Treatment Outcome; Vasodilator Agents | 2007 |
There is no scientific rationale for race-based research.
Topics: Biomarkers; Biomedical Research; Black or African American; Clinical Trials as Topic; Drug Combinations; Genetic Predisposition to Disease; Genetic Variation; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Prejudice; Racial Groups; United States | 2007 |
What's right (and wrong) with racially stratified research and therapies.
Topics: Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Biomedical Research; Black or African American; Drug Approval; Drug Combinations; Drug Industry; Genetic Predisposition to Disease; Genetic Variation; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Prejudice; Racial Groups; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration | 2007 |
BiDil: primary care physicians first and cardiologist when?
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Black or African American; Cardiology; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Practice Guidelines as Topic; Primary Health Care; Ventricular Dysfunction, Left | 2007 |
The paradox of race in the Bidil debate.
Topics: Black or African American; Drug Approval; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Racial Groups; Social Identification; United States; United States Food and Drug Administration | 2007 |
BiDil for heart failure in black patients.
Topics: Black People; Cardiovascular Agents; Drug Approval; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; United States; United States Food and Drug Administration | 2007 |
BiDil for heart failure in black patients.
Topics: Black People; Cardiovascular Agents; Drug Approval; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; United States; United States Food and Drug Administration | 2007 |
Race in a bottle. Drugmakers are eager to develop medicines targeted at ethnic groups, but so far they have made poor choices based on unsound science.
Topics: Black or African American; Drug Combinations; Drug Design; Ethnicity; Heart Diseases; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate | 2007 |
Bidil: recontextualizing the race debate.
Topics: Black or African American; Clinical Trials as Topic; Drug Approval; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Pharmacogenetics; Racial Groups; United States; United States Food and Drug Administration | 2008 |
BiDil flops.
Topics: Black People; Drug Industry; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Marketing; Massachusetts; Patents as Topic | 2008 |
[Vasodilator drugs in the therapy of chronic congestive heart failure. Clinico-case contribution].
Topics: Blood Pressure; Cardiomegaly; Chronic Disease; Drug Evaluation; Heart; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Vasodilator Agents | 1983 |
Improvement in supine bicycle exercise performance in refractory congestive heart failure after isosorbide dinitrate: radionuclide and hemodynamic evaluation of acute effects.
Topics: Aged; Blood Pressure; Cardiac Output; Electrocardiography; Erythrocytes; Heart; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Physical Exertion; Radionuclide Imaging; Sodium Pertechnetate Tc 99m; Stroke Volume; Technetium; Vascular Resistance | 1982 |
[Hemodynamic effects of intravenous isosorbide dinitrate in chronic heart failure (author's transl)].
Topics: Cardiac Catheterization; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Injections, Intravenous; Isosorbide Dinitrate; Male; Middle Aged | 1982 |
Vasodilators in the treatment of congestive heart failure.
Topics: Captopril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Minoxidil; Nitroglycerin; Nitroprusside; Prazosin; Vasodilator Agents | 1983 |
[Effect of captopril in left ventricular failure during the acute stage of myocardial infarction].
Topics: Aged; Captopril; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Proline; Renin-Angiotensin System | 1983 |
Ambulatory long-term vasodilator therapy for chronic refractory heart failure: hemodynamic evaluation and clinical response.
Topics: Adult; Aged; Ambulatory Care; Cardiac Catheterization; Cardiomyopathy, Dilated; Chronic Disease; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Hydrazines; Isosorbide Dinitrate; Long-Term Care; Male; Middle Aged; Mitral Valve Insufficiency; Stroke Volume; Todralazine | 1984 |
Hemodynamic and metabolic effects of vasodilator therapy for heart failure in acute myocardial infarction.
Topics: Blood Pressure; Cardiac Output; Coronary Circulation; Epoprostenol; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Molsidomine; Myocardial Infarction; Myocardium; Nitroglycerin; Oxygen Consumption; Sydnones; Vasodilator Agents | 1984 |
[Clinical and hemodynamic effects of an isosorbide dinitrate tape on patients with congestive heart failure--comparative study with nitroglycerin ointment].
Topics: Adult; Aged; Dosage Forms; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Ointments; Time Factors | 1983 |
[Ambulatory treatment of chronic heart failure with peripheral vasodilators].
Topics: Ambulatory Care; Chronic Disease; Drug Therapy, Combination; Heart Failure; Humans; Isosorbide Dinitrate; Nitroglycerin; Vasodilator Agents | 1984 |
Nitrates in heart failure. Pathophysiological mechanisms and therapeutic applications.
Topics: Cardiac Output; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Muscle, Smooth, Vascular; Myocardium; Nitrates; Nitroglycerin; Oxygen Consumption; Pulmonary Wedge Pressure; Vasodilation | 1984 |
Vasodilator therapy for right ventricular failure.
Topics: Adult; Aged; Alprostadil; Blood Pressure; Cardiac Output; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Hypertension, Pulmonary; Infusions, Parenteral; Isosorbide Dinitrate; Lung Diseases, Obstructive; Male; Oxygen; Partial Pressure; Physical Exertion; Prostaglandins E; Pulmonary Circulation; Pulmonary Heart Disease; Respiratory Insufficiency; Vascular Resistance | 1984 |
Nitrates in acute myocardial infarction.
Topics: Blood Pressure; Cardiac Output; Drug Interactions; Furosemide; Heart Failure; Heart Rate; Humans; Hydralazine; Isosorbide Dinitrate; Myocardial Infarction; Vascular Resistance | 1984 |
Intravenous isosorbide dinitrate in acute left ventricular failure--a dose--response study.
Topics: Adult; Aged; Cardiomyopathies; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction | 1983 |
Adjuvant therapy of chronic refractory cardiac failure with oral hydralazine and isosorbide dinitrate.
Topics: Administration, Oral; Adolescent; Adult; Aged; Chronic Disease; Digoxin; Diuretics; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Vasodilator Agents | 1983 |
Effects of disease, route of administration, cigarette smoking, food intake on the pharmacokinetics and circulatory effects of isosorbide dinitrate.
Topics: Aged; Angina Pectoris; Cardiovascular System; Eating; Female; Heart Failure; Humans; Isosorbide Dinitrate; Kinetics; Male; Middle Aged; Smoking | 1983 |
[Effects of intravenous infusion of isosorbide dinitrate (ISDN) on acute experimental congestive heart failure].
Topics: Animals; Disease Models, Animal; Dogs; Heart Failure; Hemodynamics; Infusions, Parenteral; Isosorbide Dinitrate | 1983 |
Unloading effects of molsidomine on peripheral circulation and cardiac hemodynamics in patients with acute myocardial infarction.
Topics: Adult; Aged; Blood Circulation; Blood Flow Velocity; Central Venous Pressure; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Molsidomine; Myocardial Infarction; Oxadiazoles; Plethysmography; Pulmonary Wedge Pressure; Sydnones | 1983 |
Nifedipine in hypertension and heart failure.
Topics: Adult; Aged; Blood Pressure; Delayed-Action Preparations; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans; Hypertension; Isosorbide Dinitrate; Male; Methyldopa; Middle Aged; Myocardial Infarction; Nifedipine; Propranolol; Renin-Angiotensin System | 1984 |
Effects of intraaortic balloon pumping on acute myocardial infarction in 64 cases of cardiogenic shock, severe heart failure and mechanical heart failure.
Topics: Aged; Assisted Circulation; Blood Pressure; Female; Heart Failure; Heart Rupture; Heart Septum; Heart-Lung Machine; Hemodynamics; Humans; Intra-Aortic Balloon Pumping; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Shock, Cardiogenic; Stroke Volume | 1984 |
Contrasting hemodynamic responses in severe heart failure: comparison of captopril and other vasodilator drugs.
Topics: Adult; Aged; Captopril; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Lung; Male; Middle Aged; Nitroprusside; Prazosin; Proline; Vascular Resistance; Vasodilation; Vasodilator Agents | 1982 |
Sustained hemodynamic effects without tolerance during long-term isosorbide dinitrate treatment of chronic left ventricular failure.
Topics: Adult; Blood Pressure; Chronic Disease; Diuretics; Drug Tolerance; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Long-Term Care; Middle Aged | 1980 |
Hemodynamic effects of nitrates in chronic heart failure and myocardial infarction.
Topics: Chronic Disease; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Myocardial Infarction; Nitrates; Nitroglycerin; Oxygen Consumption; Vasodilator Agents | 1980 |
Nitrate tolerance and dependence. A critical assessment.
Topics: Angina Pectoris; Animals; Dogs; Drug Tolerance; Heart Failure; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin; Rabbits; Rats; Substance-Related Disorders; Tachyphylaxis; Vasodilator Agents | 1980 |
Postural hypotension and tachycardia during hydralazine--isosorbide dinitrate therapy for chronic heart failure.
Topics: Heart Failure; Hemodynamics; Humans; Hydralazine; Hypotension, Orthostatic; Isosorbide Dinitrate; Long-Term Care; Tachycardia; Vasodilator Agents | 1981 |
Current status of hemodynamic monitoring: indication, diagnoses, complications.
Topics: Acute Disease; Arrhythmias, Cardiac; Cardiac Output; Glucose; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Insulin; Isosorbide Dinitrate; Monitoring, Physiologic; Myocardial Infarction; Nitroglycerin; Potassium; Prognosis; Shock, Cardiogenic; Stroke Volume | 1981 |
Nitrates, package inserts, and the Food and Drug Administration. A clinical paradox.
Topics: Angina Pectoris; Biological Availability; Delayed-Action Preparations; Drug Labeling; Heart Failure; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin; United States; United States Food and Drug Administration; Vasodilator Agents | 1981 |
Central and regional hemodynamic effects of intravenous isosorbide dinitrate, nitroglycerin and nitroprusside in patients with congestive heart failure.
Topics: Cardiac Output; Extremities; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Nitroprusside; Oxygen Consumption; Stroke Volume; Systole | 1981 |
Peripheral oedema in patients treated with isosorbide dinitrate.
Topics: Aged; Ankle; Edema; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction | 1981 |
Vasodilator therapy in refractory congestive heart failure: a comparative analysis of hemodynamic and noninvasive studies.
Topics: Aged; Cardiac Output; Drug Evaluation; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Ointment Bases; Prazosin; Pulmonary Wedge Pressure; Stroke Volume; Vasodilator Agents | 1982 |
[Comparison between the hemodynamic effects of nitroglycerine ointment and oral isosorbide dinitrate in the treatment of left ventricular failure (author's transl)].
Topics: Administration, Oral; Adult; Aged; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Ointments | 1981 |
[Rapid attenuation of effects of isosorbide dinitrate during long-term treatment of chronic congestive heart failure].
Topics: Chronic Disease; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Long-Term Care; Male; Middle Aged; Time Factors | 1982 |
[Trinitroglycerin ointment and oral isosorbide dinitrate: comparison of the hemodynamic effects induced in acute myocardial infarct with left ventricular insufficiency].
Topics: Aged; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nitroglycerin | 1981 |
Radiocardiographic assessment of dobutamine and isosorbide dinitrate therapy in patients with mitral stenosis and pulmonary congestion.
Topics: Adult; Aged; Blood Pressure; Blood Volume; Cardiac Output; Catecholamines; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Middle Aged; Mitral Valve Stenosis; Pulmonary Edema | 1983 |
[Use of the vasodilator nitrosorbide in the treatment of chronic heart failure].
Topics: Adolescent; Adult; Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Vasodilator Agents | 1983 |
Intravenous isosorbide dinitrate in patients with refractory pump failure and acute myocardial infarction.
Topics: Catecholamines; Coronary Disease; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Isosorbide Dinitrate; Myocardial Infarction | 1982 |
Vasodilators in heart failure secondary to coronary artery disease.
Topics: Cardiac Output; Coronary Disease; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Myocardium; Oxygen Consumption; Prazosin; Pulmonary Wedge Pressure; Time Factors; Vasodilator Agents | 1982 |
Hemodynamic effects of vasodilator therapy in severe left heart failure combined with large atrial septal defects.
Topics: Blood Pressure; Heart Failure; Heart Septal Defects, Atrial; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Vascular Resistance; Vasodilator Agents | 1982 |
[Chronic use of vasodilators in the therapy of congestive cardiac insufficiency].
Topics: Drug Administration Schedule; Heart Failure; Heart Function Tests; Humans; Isosorbide Dinitrate; Prazosin; Vasodilator Agents | 1982 |
[Atrial complex of the electrocardiogram in the light of drug-induced hemodynamic changes in patients in the acute stage of myocardial infarction].
Topics: Adult; Aged; Blood Pressure; Electrocardiography; Heart Atria; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Pulmonary Artery | 1982 |
Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure.
Topics: Adult; Aged; Chronic Disease; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Middle Aged; Physical Exertion | 1981 |
[Comparative invasive examination of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in chronic coronary insufficiency].
Topics: Chronic Disease; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate | 1981 |
Results of long-term vasodilator therapy in patients with refractory congestive heart failure.
Topics: Administration, Oral; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Vasodilator Agents | 1981 |
Determinants of drug response in severe chronic heart failure. 1. Activation of vasoconstrictor forces during vasodilator therapy.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Cardiac Output; Chronic Disease; Female; Ferricyanides; Heart Failure; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroprusside; Phentolamine; Stimulation, Chemical; Vascular Resistance; Vasoconstriction | 1981 |
[The end-systolic pressure-volume relationship in the assessment of left ventricular function (author's transl)].
Topics: Atropine; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiac Volume; Coronary Disease; Heart Failure; Heart Rate; Heart Ventricles; Humans; Isosorbide Dinitrate; Methoxamine; Myocardial Contraction; Propranolol; Stroke Volume; Systole | 1981 |
Sublingual isosorbide dinitrate in severe congestive heart failure.
Topics: Blood Pressure; Heart Failure; Humans; Isosorbide Dinitrate; Pulmonary Wedge Pressure | 1981 |
New approaches to the diagnosis and management of acute cardiac failure.
Topics: Acute Disease; Cardiac Output; Electrocardiography; Heart Failure; Heart Rate; Hemodynamics; Humans; Isosorbide Dinitrate; Myocardial Contraction; Pulmonary Wedge Pressure; Vasodilator Agents | 1981 |
[Vasodilator therapy of pump failure in acute myocardial infarction].
Topics: Adult; Aged; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nitroprusside; Prazosin; Quinazolines; Vasodilator Agents | 1980 |
Effects of isosorbide dinitrate and hydralazine on regional metabolic responses to arm exercise in patients with heart failure.
Topics: Adult; Arm; Female; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Lactates; Lactic Acid; Male; Middle Aged; Muscles; Oxygen Consumption; Physical Exertion | 1981 |
[Hemodynamic effects of combined isosorbide dinitrate-nifedipine therapy in congestive heart failure (author's transl)].
Topics: Aged; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Pyridines | 1981 |
Slow-channel calcium blockers in heart failure: a plea for cautious optimism.
Topics: Calcium Channel Blockers; Heart Failure; Humans; Isosorbide Dinitrate; Myocardial Infarction; Nifedipine; Vasodilator Agents | 1981 |
Comparison of acute haemodynamic effects of nifedipine and isosorbide dinitrate in patients with heart failure following acute myocardial infarction.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nifedipine; Pyridines; Stroke Volume; Vascular Resistance | 1981 |
Combined vasodilator therapy in the treatment of chronic heart failure.
Topics: Blood Pressure; Drug Therapy, Combination; Heart Failure; Heart Rate; Humans; Hydralazine; Isosorbide Dinitrate | 1981 |
Is there a drug of choice for vasodilator therapy in patients with refractory heart failure?
Topics: Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Phentolamine; Prazosin; Vasodilator Agents | 1980 |
Effects of vasodilators on pulmonary hemodynamics and gas exchange in left ventricular failure.
Topics: Adult; Aged; Blood Gas Analysis; Blood Pressure; Ferricyanides; Heart Failure; Heart Rate; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Lung; Male; Middle Aged; Nitroprusside; Respiratory Function Tests; Stroke Volume; Vasodilator Agents | 1980 |
Radionuclide and hemodynamic assessment of left ventricular functional reserve in patients with left ventricular aneurysm and congestive cardiac failure. Response to exercise stress and isosorbide dinitrate.
Topics: Adult; Female; Heart Aneurysm; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Contraction; Physical Exertion; Radionuclide Imaging; Stroke Volume | 1980 |
Haemodynamic effects of oral salbutamol alone and in combination with sublingual isosorbide dinitrate in patients with severe congestive cardiac failure.
Topics: Aged; Albuterol; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1980 |
Influence of vasodilator therapy on prognosis of acute myocardial infarction in the aged patients. A comparative study between vasodilator-treated group and group treated without vasodilator.
Topics: Age Factors; Aged; Chlorpromazine; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Myocardial Infarction; Prognosis; Time Factors; Vasodilator Agents | 1980 |
Left ventricular aneurysm and congestive heart failure: value of exercise stress and isosorbide dinitrate in predicting hemodynamic results of aneurysmectomy.
Topics: Adult; Aged; Cardiac Output; Cineangiography; Coronary Angiography; Exercise Test; Female; Heart Aneurysm; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Stroke Volume; Time Factors | 1980 |
Drug regimens for congestive heart failure.
Topics: Cardiac Glycosides; Cardiotonic Agents; Dobutamine; Heart; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Vasodilator Agents | 1980 |
[The long-acting effects of isosorbide dinitrate on left ventricular performance in congestive heart insufficiency. Phonocardiographic study].
Topics: Adult; Delayed-Action Preparations; Female; Heart Failure; Heart Ventricles; Humans; Isosorbide Dinitrate; Male; Middle Aged; Phonocardiography | 1980 |
Effects of vasodilators on renal function in severe heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Heart Failure; Humans; Isosorbide Dinitrate; Kidney; Middle Aged; Prazosin; Vasodilator Agents | 1980 |
[Evaluation of long-term treatment with isosorbide dinitrate and prazosin in cardiac insufficiency].
Topics: Adult; Aged; Digoxin; Drug Evaluation; Female; Furosemide; Heart Failure; Heart Rate; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Prazosin; Quinazolines; Time Factors | 1980 |
Escalating nitrate dose overcomes early attenuation of hemodynamic effect caused by nitrate tolerance in patients with heart failure.
Topics: Adult; Aged; Blood Pressure; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Pulmonary Artery; Pulmonary Wedge Pressure; Ventricular Dysfunction, Left | 1995 |
A characteristic change in ventilation mode during exertional dyspnea in patients with chronic heart failure.
Topics: Dyspnea; Exercise Test; Exercise Tolerance; Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Pulmonary Gas Exchange; Reproducibility of Results; Respiration; Tidal Volume | 1994 |
Doppler diastolic transmitral flow patterns in severe heart failure: response to controlled changes in filling pressure using intravenous isosorbide dinitrate.
Topics: Aged; Blood Flow Velocity; Diastole; Echocardiography, Doppler; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Isosorbide Dinitrate; Male; Middle Aged; Mitral Valve; Ventricular Function, Left | 1994 |
Pulmonary function tests in patients with congestive heart failure: effects of medical therapy.
Topics: Adult; Aged; Captopril; Cardiovascular Agents; Digoxin; Dobutamine; Drug Therapy, Combination; Echocardiography, Doppler; Forced Expiratory Volume; Furosemide; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Nitroprusside; Vasodilator Agents; Vital Capacity | 1993 |
1,4:3,6-Dianhydrohexitol nitrate derivatives. I. Synthesis and antianginal activity of alkylpiperazine derivatives.
Topics: Administration, Oral; Angina Pectoris; Animals; Anti-Arrhythmia Agents; Blood Pressure; Disease Models, Animal; Dogs; Electrocardiography; Female; Heart Failure; Heart Rate; Isosorbide Dinitrate; Lypressin; Male; Piperazines; Propranolol; Rats; Rats, Wistar; Vasodilator Agents | 1993 |
1,4:3,6-Dianhydrohexitol nitrate derivatives. II. Synthesis and antianginal activity of aryl- or arylcarbonylpiperazine derivatives.
Topics: Angina Pectoris; Animals; Central Nervous System; Disease Models, Animal; Dogs; Drug Design; Female; Heart Failure; Isosorbide Dinitrate; Lypressin; Male; Mice; Myocardial Ischemia; Piperazines; Rats; Rats, Wistar; Structure-Activity Relationship; Vasodilator Agents | 1993 |
Nitrate tolerance--problems both new and old.
Topics: Administration, Cutaneous; Administration, Oral; Angina Pectoris; Delayed-Action Preparations; Drug Tolerance; Heart Failure; Humans; Injections, Intravenous; Isosorbide Dinitrate; Myocardial Ischemia; Nitroglycerin; Vasodilator Agents | 1996 |
Reversal of end-stage heart failure is predicted by long-term therapeutic response rather than initial hemodynamic and neurohormonal profile.
Topics: Adult; Cardiovascular Agents; Dobutamine; Dose-Response Relationship, Drug; Enalapril; Female; Follow-Up Studies; Furosemide; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Norepinephrine; Survival Rate; Treatment Outcome; Waiting Lists | 1996 |
[Therapeutic range of transdermal nitro-patches].
Topics: Administration, Cutaneous; Angina Pectoris; Arrhythmias, Cardiac; Evaluation Studies as Topic; Heart Diseases; Heart Failure; Heart Rupture; Hemodynamics; Humans; Isosorbide Dinitrate; Myocardial Infarction; Nitroglycerin; Recurrence; Time Factors; Vasodilator Agents | 1995 |
[What is the value of organic nitrate preparations in treatment of chronic heart failure?].
Topics: Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Survival Rate; Treatment Outcome; Vasodilator Agents | 1996 |
Response of symptomatic myocardial ischemia in ischemic cardiomyopathy to intensive vasodilator therapy.
Topics: Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Enalapril; Heart Failure; Humans; Isosorbide Dinitrate; Middle Aged; Retrospective Studies; Treatment Outcome; Vasodilator Agents | 1997 |
Reverse remodeling in heart failure with intensification of vasodilator therapy.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Case-Control Studies; Cohort Studies; Drug Therapy, Combination; Echocardiography, Doppler; Enalapril; Female; Follow-Up Studies; Heart Failure; Humans; Hypertrophy, Left Ventricular; Isosorbide Dinitrate; Male; Middle Aged; Time Factors; Vasodilator Agents; Ventricular Function, Left | 1997 |
Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure.
Topics: Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Captopril; Cardiac Output; Diuretics; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Vasodilator Agents; Ventricular Pressure | 1997 |
The AHCPR clinical practice guideline for heart failure revisited.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Calcium Channel Blockers; Cardiac Output, Low; Digoxin; Diuretics; Female; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Ventricular Dysfunction, Left | 1997 |
Acute changes of left atrial distensibility in congestive heart failure.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cardiac Catheterization; Cardiomyopathy, Dilated; Dobutamine; Echocardiography; Female; Heart Atria; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Ischemia; Predictive Value of Tests; Propanolamines; Vasodilator Agents | 1998 |
Tailored therapy using dobutamine and nitroglycerin in advanced heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Hypertension, Pulmonary; Infusions, Intravenous; Infusions, Parenteral; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Retrospective Studies; Treatment Outcome; Vasodilator Agents | 1999 |
Reversal of heart failure remodeling in women.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Echocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Isosorbide Dinitrate; Lisinopril; Male; Middle Aged; Prospective Studies; Retrospective Studies; Sex Factors; Treatment Outcome; Vasodilator Agents; Ventricular Remodeling | 2000 |
Intermittent nitrate therapy for prior myocardial infaraction does not induce rebound angina nor reduce cardiac events.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Angina Pectoris; Cardiovascular Agents; Coronary Vasospasm; Delayed-Action Preparations; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Exercise Tolerance; Female; Follow-Up Studies; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Recurrence; Retrospective Studies; Treatment Outcome | 2000 |
Acute congestive heart failure associated with a limited form of systemic sclerosis and primary biliary cirrhosis.
Topics: Acute Disease; Antibody Specificity; Autoantibodies; Autoimmune Diseases; Centromere; Coronary Circulation; Dyspnea; Female; Furosemide; Heart Failure; Humans; Isosorbide Dinitrate; Liver Cirrhosis, Biliary; Microcirculation; Microsomes, Liver; Middle Aged; Nitroglycerin; Radionuclide Imaging; Raynaud Disease; Scleroderma, Systemic; Skin; Thallium Radioisotopes | 2001 |
Dobutamine as bridge to angiotensin-converting enzyme inhibitor-nitrate therapy in endstage heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Heart Failure; Humans; Isosorbide Dinitrate; Lisinopril; Prospective Studies; Stroke Volume; Treatment Outcome; Ultrasonography; Vasodilator Agents | 2001 |
Tailored treatments.
Topics: Black or African American; Cardiovascular Agents; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate | 2001 |
Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Fibrillation; Dogs; Electrophysiology; Enalapril; Endomyocardial Fibrosis; Heart Atria; Heart Failure; Hemodynamics; Hydralazine; Isosorbide Dinitrate; Mitogen-Activated Protein Kinases; Renin-Angiotensin System; Signal Transduction; Tachycardia, Ventricular | 2001 |
Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise.
Topics: Chronic Disease; Drug Therapy, Combination; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Lupus Erythematosus, Systemic; Nitroglycerin; Physical Exertion; Prazosin; Pressure; Rest; Time Factors; Vasodilator Agents | 1978 |
[2. International Symposium on Nitrates; Berlin 1-3 June 1978. Nitrate-effect on the heart and circulation].
Topics: Angina Pectoris; Animals; Blood Circulation; Coronary Disease; Heart; Heart Failure; Humans; Isosorbide Dinitrate; Male; Myocardial Infarction; Nitrates; Nitroglycerin; Nitroprusside; Rats | 1978 |
[Peroral nitrate therapy in severe cardiac insufficiency following acute myocardial infarct].
Topics: Administration, Oral; Aged; Delayed-Action Preparations; Heart Failure; Humans; Isosorbide Dinitrate; Middle Aged; Myocardial Infarction; Nitrates; Nitroglycerin | 1978 |
[Long-term treatment of chronic congestive heart failure with oral isosorbide dinitrate and phenotoline (author's transl)].
Topics: Administration, Oral; Adult; Aged; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Long-Term Care; Male; Middle Aged; Phentolamine | 1979 |
[Hemodynamic effects of oral dihydralazine and sublingual isosorbide dinitrate, alone and in combination in chronic heart failure].
Topics: Administration, Oral; Aged; Chronic Disease; Dihydralazine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Mouth Floor | 1979 |
Ventricular unloading in the management of heart disease: role of vasodilators. Part II.
Topics: Cardiomyopathy, Hypertrophic; Coronary Artery Bypass; Dosage Forms; Heart Diseases; Heart Failure; Heart Valve Diseases; Hemodynamics; Humans; Isosorbide Dinitrate; Myocardial Contraction; Myocardial Infarction; Nitroglycerin; Nitroprusside; Postoperative Complications; Vasodilator Agents | 1977 |
Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Cardiac Output; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Vascular Resistance; Vasodilator Agents | 1977 |
Current clinical status of nitroglycerin and other nitrates.
Topics: Angina Pectoris; Heart Diseases; Heart Failure; Humans; Isosorbide Dinitrate; Myocardial Infarction; Nitroglycerin; Nitroprusside | 1978 |
Haemodynamic effects of isosorbide dinitrate in patients with congestive cardiac failure at rest and during submaximal supine exercise.
Topics: Administration, Oral; Aged; Cardiac Output; Coronary Angiography; Coronary Disease; Drug Evaluation; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Physical Exertion; Pulmonary Circulation | 1978 |
Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure.
Topics: Administration, Oral; Aged; Blood Pressure; Cardiac Output; Drug Evaluation; Heart Failure; Heart Rate; Hemodynamics; Humans; Isosorbide Dinitrate; Middle Aged; Myocardial Contraction; Oxygen Consumption; Physical Exertion; Pulmonary Circulation; Vascular Resistance | 1979 |
[Clinical and hemodynamic evaluation of isosorbide dinitrate therapy in heart failure (author's transl)].
Topics: Aged; Blood Pressure; Cardiac Output; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Middle Aged | 1979 |
[Premises on the use of vasodilator agents. The venous or mixed vasodilators].
Topics: Heart Failure; Humans; Isosorbide Dinitrate; Prazosin; Vasodilator Agents | 1979 |
[Treatment of advanced heart failure with hydralazine and isosorbide dinitrate (author's transl)].
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydralazine; Isosorbide; Isosorbide Dinitrate; Male; Middle Aged | 1979 |
Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside.
Topics: Administration, Oral; Aged; Blood Pressure; Cardiac Output; Drug Therapy, Combination; Heart Failure; Heart Rate; Hemodynamics; Humans; Hydralazine; Infusions, Parenteral; Isosorbide Dinitrate; Middle Aged; Nitroprusside; Vascular Resistance | 1978 |
[Vasodilator therapy by isosorbide dinitrate for the patients with congestive heart failure (author's transl)].
Topics: Adult; Aged; Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1978 |
Vasodilator therapy for congestive heart failure--new use for old drugs.
Topics: Heart Failure; Heart Ventricles; Hemodynamics; Humans; Isosorbide Dinitrate; Time Factors; Vasodilator Agents | 1978 |
[Vasodilator therapy in congestive heart failure--hemodynamic effects of oral administered isosorbide dinitrate (author's transl)].
Topics: Administration, Oral; Adult; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1978 |
New and traditional therapy of congestive heart failure. A European view.
Topics: Delayed-Action Preparations; Digitalis Glycosides; Diuretics; Dobutamine; Heart Failure; Humans; Isosorbide Dinitrate; Nitroprusside; Phentolamine | 1978 |
Improvement in exercise haemodynamics by isosorbide dinitrate in patients with severe congestive cardiac failure secondary to ischaemic heart disease.
Topics: Aged; Blood Pressure; Cardiac Output; Coronary Disease; Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Physical Exertion | 1978 |
Enhancement by isosorbide dinitrate of haemodynamic effects of dopamine in chronic congestive cardiac failure.
Topics: Aged; Blood Pressure; Cardiac Output; Dopamine; Drug Therapy, Combination; Heart Failure; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1978 |
Use of vasodilator drugs in congestive heart failure.
Topics: Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitroprusside; Prazosin; Vasodilator Agents | 1978 |
The effect of isosorbide dinitrate on left ventricular size, wall stress and left ventricular function in chronic refractory heart failure. An echocardiographic study.
Topics: Adult; Aged; Blood Pressure; Echocardiography; Heart; Heart Failure; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1978 |
Vasodilator therapy in mitral regurgitation with chronic heart failure.
Topics: Adolescent; Adult; Child; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Mitral Valve Insufficiency | 1978 |
[Sodium nitroprusside in the treatment of severe left ventricular insufficiency in acute myocardial infarct. Personal clinical experience and hemodynamic considerations].
Topics: Aged; Digitalis Glycosides; Diuretics; Drug Therapy, Combination; Ferricyanides; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nitroprusside | 1978 |
Isosorbide dinitrate in acute and chronic heart failure.
Topics: Acute Disease; Adult; Aged; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Time Factors | 1979 |
[New aspects of the treatment of left ventricular failure: Nitroglycerin (author's transl)].
Topics: Acute Disease; Administration, Oral; Aged; Arteries; Blood Pressure; Cardiac Catheterization; Cardiac Output; Chronic Disease; Coronary Disease; Heart Failure; Heart Ventricles; Humans; Injections, Intravenous; Isosorbide Dinitrate; Male; Myocardial Infarction; Nitroglycerin; Pulmonary Edema; Tongue | 1975 |
Vasodilator therapy for chronic left ventricular failure.
Topics: Adult; Aged; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Nitroprusside; Vasodilator Agents | 1976 |
Peripheral vasodilators in the treatment of cardiac failure.
Topics: Blood Pressure; Cardiac Output; Coronary Circulation; Dose-Response Relationship, Drug; Heart Failure; Humans; Isosorbide Dinitrate; Lactates; Mitral Valve Insufficiency; Myocardial Infarction; Myocardium; Nitroglycerin; Nitroprusside; Oxygen Consumption; Vascular Resistance; Vasodilator Agents | 1976 |
Letter: Cardiac failure.
Topics: Heart Failure; Humans; Isosorbide Dinitrate; Nitrites; Nitroglycerin | 1976 |
Combination vasodilator therapy for severe chronic congestive heart failure.
Topics: Chronic Disease; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Minoxidil; Nitroglycerin; Nitroprusside; Vasodilator Agents | 1976 |
Treatment of congestive heart failure.
Topics: Benzothiadiazines; Bloodletting; Digitalis Glycosides; Diuretics; Heart; Heart Failure; Heart Function Tests; Hemodynamics; Humans; Isosorbide Dinitrate; Morphine; Myocardial Contraction; Nitroglycerin; Nitroprusside; Rest; Sodium Chloride Symporter Inhibitors; Stimulation, Chemical | 1976 |
[Effect of sublingual isosorbide dinitrate on hemodynamics in coronary patients with and without congestive heart failure (author's transl)].
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Coronary Disease; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Middle Aged; Myocardial Infarction; Pulmonary Artery; Vascular Resistance | 1977 |
[Isotope study of the effects of a nitrate derivative on pulmonary blood volume. Application in the treatment of cardiogenic pulmonary edema].
Topics: Aged; Blood Pressure; Blood Volume; Capillary Resistance; Depression, Chemical; Heart Failure; Heart Ventricles; Humans; Isosorbide Dinitrate; Lung; Middle Aged; Nitrates; Pulmonary Circulation; Pulmonary Edema | 1976 |
[Hemodynamic changes in the acute phase of myocardial infarct. Clinico-therapeutic implications. Preliminary report].
Topics: Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Myocardial Infarction | 1976 |
Letter: Vasodilators in heart failure.
Topics: Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Vasodilator Agents | 1975 |
[Effect of nitroglycerin in acute myocardial infarction. III. Isosorbide dinitrate in patients with or without left-heart failure (author's transl)].
Topics: Acute Disease; Administration, Oral; Adult; Aged; Blood Pressure; Cardiac Output; Female; Heart Failure; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Pulmonary Artery | 1975 |
Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Cardiac Output; Coronary Circulation; Drug Evaluation; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Isosorbide Dinitrate; Lactates; Male; Middle Aged; Myocardium; Oxygen Consumption; Pulmonary Circulation; Tablets; Vascular Resistance; Venous Pressure | 1975 |
[Proceedings: Left ventricular function in congestive cardiomyopathy and the effect of nitrates].
Topics: Cardiac Output; Heart Failure; Heart Rate; Heart Ventricles; Humans; Isosorbide Dinitrate; Myocardial Contraction; Pulse | 1975 |
[Haemodynamic effects of intravenous isosorbide dinitrate in congestive heart failure].
Topics: Aged; Aged, 80 and over; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Isosorbide Dinitrate; Male | 1992 |
Persistent hemodynamic improvement with short-term nitrate therapy in patients with chronic congestive heart failure already treated with captopril.
Topics: Adult; Aged; Blood Pressure; Captopril; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Pulmonary Artery; Pulmonary Wedge Pressure | 1992 |
[Acute hemodynamic effects of intravenous bolus injection of isosorbide dinitrate in aged patients with congestive heart failure].
Topics: Aged; Aged, 80 and over; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Isosorbide Dinitrate; Male; Middle Aged | 1992 |
[Doppler echocardiographic evaluation of vasodilator treatments in patients with cardiac insufficiency. Contribution to the combination of isosorbide dinitrate and captopril].
Topics: Aged; Captopril; Drug Therapy, Combination; Echocardiography, Doppler; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Ventricular Function, Left | 1992 |
Nitrate tolerance. How to prevent it or minimize its effect.
Topics: Angina Pectoris; Drug Tolerance; Heart Failure; Humans; Isosorbide Dinitrate; Nitroglycerin | 1992 |
Calcium antagonist caution.
Topics: Calcium Channel Blockers; Contraindications; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Nifedipine; Ventricular Function, Left | 1991 |
Transient pulsus alternans induced by isosorbide dinitrate: echocardiographic and hemodynamic evidence of reduced venous return--a case report.
Topics: Adult; Drug Therapy, Combination; Echocardiography; Furosemide; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Pulse | 1991 |
[Coronary insufficiency: symptoms and diagnostic assessment. Causal/symptomatic therapy].
Topics: Coronary Disease; Diltiazem; Drug Therapy, Combination; Electrocardiography, Ambulatory; Heart Failure; Humans; Isosorbide Dinitrate; Myocardial Infarction | 1990 |
[Effect of nitrates on left ventricular function and exercise tolerance in patients with mild circulatory failure caused by ischemic heart disease].
Topics: Adult; Aged; Aged, 80 and over; Coronary Disease; Echocardiography; Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Physical Exertion; Ventricular Function, Left | 1990 |
Long-term effect of isosorbide dinitrate and nifedipine, singly and in association, in patients with chronic heart failure.
Topics: Blood Pressure; Cardiac Output; Chronic Disease; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Nifedipine; Pulmonary Circulation; Vascular Resistance | 1990 |
Can we expect vasodilator therapy to prolong life in patients with congestive heart failure?
Topics: Drug Therapy, Combination; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Time Factors; Vasodilator Agents | 1987 |
Nitrate therapy for left ventricular failure complicating acute myocardial infarction: a haemodynamic comparison of intravenous, buccal, and transdermal delivery systems.
Topics: Administration, Buccal; Administration, Cutaneous; Administration, Oral; Adult; Aged; Blood Pressure; Cardiac Output; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nitroglycerin | 1989 |
Follow-up the haemodynamic effect of nitroglycerin and determination of the optimal dose using the non-invasive and invasive methods in patients treated at the intensive care unit.
Topics: Aged; Aged, 80 and over; Coronary Disease; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Intensive Care Units; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin | 1989 |
[Effects of isosorbide-5-mononitrate on exercise capacity, prostacyclin synthesis, the renin-aldosterone axis and catecholamines in patients with cardiac insufficiency].
Topics: Aged; Catecholamines; Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Physical Endurance; Prostaglandins F; Renin-Angiotensin System; Time Factors | 1989 |
Effect of isosorbide dinitrate on cardiac output in severe cardiac failure: relation to initial hemodynamics, ventricular volume, and the preload reserve mechanism.
Topics: Aged; Blood Volume; Cardiac Output; Coronary Circulation; Diastole; Dose-Response Relationship, Drug; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Isosorbide Dinitrate; Middle Aged | 1989 |
Dose-ranging study of isosorbide-5-mononitrate in chronic congestive heart failure treated with diuretics and angiotensin-converting enzyme inhibitor.
Topics: Aged; Blood Pressure; Cardiac Output; Chronic Disease; Diuretics; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Pulmonary Wedge Pressure | 1988 |
[New approaches to the study of the mechanism of action of nitrates].
Topics: Blood Platelets; Calcium; Calcium Channel Blockers; Calcium Channels; Cardiomegaly; Ferricyanides; Heart Failure; Humans; In Vitro Techniques; Isosorbide Dinitrate; Nitroglycerin; Nitroprusside; Receptors, Cell Surface | 1988 |
Current indications for vasodilator therapy for left ventricular failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Minoxidil; Myocardial Infarction; Nitroprusside; Prazosin; Vasodilator Agents | 1985 |
Advantage of combined therapy with captopril and nitrates in severe congestive heart failure.
Topics: Blood Pressure; Captopril; Cardiac Output; Drug Combinations; Heart Failure; Humans; Isosorbide Dinitrate; Myocardial Contraction; Pulmonary Artery; Stroke Volume; Vascular Resistance | 1988 |
Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Blood Pressure; Cardiac Output; Dose-Response Relationship, Drug; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Substance Withdrawal Syndrome; Time Factors; Vascular Resistance | 1986 |
[Long-term vasodilator therapy of chronic refractory heart failure in patients with dilated cardiomyopathy].
Topics: Adult; Aged; Cardiomyopathy, Dilated; Chronic Disease; Drug Therapy, Combination; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Long-Term Care; Male; Middle Aged; Todralazine; Vasodilator Agents | 1986 |
[Comparative evaluation of the efficacy of nitrosorbide and nitroglycerin in acute myocardial infarct patients].
Topics: Acute Disease; Angina Pectoris; Arrhythmias, Cardiac; Dyspnea, Paroxysmal; Electrocardiography; Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Time Factors | 1987 |
Application of a combination of sublingually administered vasodilating drugs for rapid action on pulmonary hypertension in patients with cardiac asthma and with pulmonary oedema.
Topics: Administration, Oral; Adult; Aged; Drug Therapy, Combination; Dyspnea, Paroxysmal; Female; Heart Failure; Humans; Hypertension, Pulmonary; Isosorbide Dinitrate; Male; Middle Aged; Molsidomine; Nitroglycerin; Pulmonary Edema; Vasodilator Agents | 1987 |
Role of nitrates in congestive heart failure.
Topics: Dosage Forms; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Nitroglycerin | 1987 |
[Hemodynamic effect of unloading therapy in acute myocardial infarction with congestive heart failure].
Topics: Age Factors; Aged; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Nitroprusside | 1987 |
Comparative evaluation of isosorbide-5-mononitrate and nitroglycerin in chronic congestive heart failure.
Topics: Aged; Blood Pressure; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Nitroglycerin | 1988 |
Nitrates: the problem of tolerance.
Topics: Angina Pectoris; Drug Tolerance; Heart Failure; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin | 1988 |
[Hemodynamic effects of isosorbide dinitrate (Isomack Retard capsules) in chronic heart failure].
Topics: Aged; Aged, 80 and over; Delayed-Action Preparations; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Tablets | 1988 |
[Systolic intervals in dilated heart insufficiency. Influence of vasodilator treatment].
Topics: Aged; Captopril; Female; Heart Failure; Heart Ventricles; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Contraction; Systole; Vasodilator Agents | 1988 |
Regional blood flow and hemodynamics in the rabbit with adriamycin cardiomyopathy: effects of isosorbide dinitrate, dobutamine and captopril.
Topics: Animals; Captopril; Cardiomyopathies; Dobutamine; Doxorubicin; Heart Failure; Hemodynamics; Isosorbide Dinitrate; Rabbits; Regional Blood Flow | 1987 |
Intravenous isosorbide dinitrate during open-heart surgery and its role in the treatment of right-sided congestive heart failure.
Topics: Cardiac Surgical Procedures; Cardiopulmonary Bypass; Heart Failure; Hemodynamics; Humans; Hypertension, Pulmonary; Injections, Intravenous; Intraoperative Care; Isosorbide Dinitrate | 1988 |
Radionuclear measurement of peripheral hemodynamics in selection of vasodilators for treatment of heart failure.
Topics: Aged; Arm; Blood Flow Velocity; Blood Volume; Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Prazosin; Radionuclide Imaging; Stroke Volume; Vascular Resistance; Vasodilator Agents; Veins | 1988 |
[The effect of a single administration of isosorbide dinitrate (Isoket ampules) in heart failure].
Topics: Aged; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Isosorbide Dinitrate; Male; Middle Aged | 1988 |
Haemodynamic effects of intravenous isosorbide-5-mononitrate in acute and chronic left heart failure of ischaemic aetiology.
Topics: Aged; Blood Pressure; Cardiac Output; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Pulmonary Wedge Pressure | 1988 |
Resistance to isosorbide dinitrate in patients with severe chronic heart failure: incidence and attempt at hemodynamic prediction.
Topics: Adult; Aged; Blood Pressure; Chronic Disease; Dose-Response Relationship, Drug; Drug Resistance; Female; Forecasting; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1988 |
[Clinical use of slow-release isosorbide-5-mononitrate in cardiac insufficiency].
Topics: Aged; Delayed-Action Preparations; Drug Evaluation; Exercise Test; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Middle Aged; Random Allocation | 1987 |
Effects of captopril and a combination of hydralazine and isosorbide dinitrate on myocardial sympathetic tone in patients with severe congestive heart failure.
Topics: Aged; Blood Pressure; Captopril; Drug Therapy, Combination; Epinephrine; Female; Heart Failure; Heart Rate; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Norepinephrine; Pulmonary Wedge Pressure; Vascular Resistance | 1986 |
Oral isosorbide-5-mononitrate: pharmacokinetics and clinical efficacy.
Topics: Administration, Oral; Coronary Disease; Drug Tolerance; Half-Life; Headache; Heart Failure; Humans; Isosorbide Dinitrate; Kidney Failure, Chronic; Kinetics; Liver Cirrhosis; Male | 1987 |
Isosorbide dinitrate oral spray in acute exacerbation of chronic congestive heart failure secondary to coronary artery disease.
Topics: Administration, Oral; Adult; Aerosols; Aged; Coronary Disease; Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1987 |
Isosorbide 5-mononitrate in the treatment of left ventricular failure following acute myocardial infarction.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Blood Pressure; Cardiac Output; Heart Failure; Heart Rate; Humans; Injections, Intravenous; Isosorbide Dinitrate; Middle Aged; Myocardial Infarction | 1987 |
Acute and chronic use of isosorbide 5-mononitrate in patients with heart failure.
Topics: Cardiomyopathy, Dilated; Coronary Disease; Digoxin; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Middle Aged | 1987 |
[Effect of peripheral vasodilators on pulmonary respiratory function and the indices of bicycle spiroergometry in heart failure patients].
Topics: Adolescent; Adult; Delayed-Action Preparations; Drug Evaluation; Exercise Test; Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Respiration; Spirometry; Vasodilator Agents | 1987 |
[Effect of peripheral vasodilators on thrombocyte aggregation in chronic circulatory insufficiency].
Topics: Adult; Aged; Chronic Disease; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Platelet Aggregation; Vasodilator Agents | 1986 |
Isosorbide-5-mononitrate in the treatment of acute left ventricular failure following acute myocardial infarction.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Female; Heart Failure; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Pulmonary Circulation; Time Factors | 1986 |
[Effect of nitrosorbide on blood circulation in patients with heart failure].
Topics: Adult; Blood Circulation; Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Vasodilator Agents | 1986 |
Vasodilator therapy in congestive heart failure.
Topics: Heart Failure; Humans; Isosorbide Dinitrate; Prazosin; Random Allocation | 1986 |
[The effect of isosorbide dinitrate-VUFB using right-sided heart catheterization].
Topics: Adult; Cardiac Catheterization; Echocardiography; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Stroke Volume | 1986 |
[Comparative evaluation of the effect of phentolamine and nitrosorbide on the central hemodynamics of children with chronic heart failure].
Topics: Adolescent; Child; Child, Preschool; Chronic Disease; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Phentolamine | 1986 |
[Suppression of complex ventricular arrhythmias with isosorbide dinitrate in a case of congestive heart failure].
Topics: Aged; Arrhythmias, Cardiac; Drug Evaluation; Female; Heart Failure; Heart Ventricles; Humans; Isosorbide Dinitrate | 1985 |
[Risordan].
Topics: Angina Pectoris; Heart Failure; Humans; Isosorbide Dinitrate | 1985 |
[Significance of nitrates in acute therapy of heart failure with and without lung edema].
Topics: Cardiac Output, Low; Cardiomyopathy, Dilated; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin; Pulmonary Edema; Regional Blood Flow; Shock, Cardiogenic | 1985 |
[Comparative evaluation of the effectiveness of various peripheral vasodilators in the treatment of cardiac insufficiency].
Topics: Administration, Oral; Adolescent; Adult; Captopril; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Prazosin; Vasodilator Agents | 1985 |
[Nitrates in the complex treatment of circulatory failure].
Topics: Adult; Aged; Cardiac Glycosides; Drug Therapy, Combination; Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin | 1985 |
[Vasodilators in chronic heart insufficiency].
Topics: Calcium Channel Blockers; Dihydralazine; Heart Failure; Humans; Isosorbide Dinitrate; Prazosin; Vasodilator Agents | 1986 |
Postural influences on the hemodynamic responses to vasodilating drugs in congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Clonidine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Posture; Pulmonary Artery; Pulmonary Wedge Pressure; Vascular Resistance; Vasodilator Agents | 1985 |
[Peripheral vasodilator in cardiac insufficiency in the acute period of myocardial infarction].
Topics: Cardiomyopathy, Dilated; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Myocardial Infarction; Nifedipine; Vasodilator Agents | 1985 |
Haemodynamic effects of Isodinit (isosorbide dinitrate) in acute myocardial infarction.
Topics: Adult; Aged; Blood Pressure; Female; Heart Failure; Hemodynamics; Humans; Hypertension, Pulmonary; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Stroke Volume | 1985 |
[Clinical and hemodynamic effects of continuous intravenous injection of isosorbide dinitrate in patients with congestive heart failure].
Topics: Aged; Blood Gas Analysis; Catecholamines; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Renin-Angiotensin System | 1985 |
A practical approach to the management of angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arm; Arrhythmias, Cardiac; Digitalis Glycosides; Diuretics; Exercise Therapy; Heart Failure; Humans; Isosorbide Dinitrate; Meperidine; Nitroglycerin; Physical Exertion; Stress, Psychological | 1974 |
[Proceedings: Oral nitroglycerin preparations in the therapy of left heart failure in acute myocardial infarct].
Topics: Administration, Oral; Heart Failure; Humans; Isosorbide Dinitrate; Myocardial Infarction; Nitroglycerin | 1974 |
The "natural" history of severe angina pectoris with intensive medical therapy alone: a five year prospective study of 133 patients.
Topics: Adult; Aged; Aging; Angina Pectoris; Atrial Fibrillation; Cardiomegaly; Cerebrovascular Disorders; Diabetes Complications; Electrocardiography; Female; Heart Auscultation; Heart Failure; Humans; Hypertension; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Prognosis; Propranolol; Prospective Studies | 1974 |
Chronic vasodilator therapy in the management of cardiogenic shock and intractable left ventricular failure.
Topics: Blood Pressure; Cardiac Output; Digoxin; Drug Evaluation; Ferricyanides; Furosemide; Heart Failure; Humans; Infusions, Parenteral; Isosorbide Dinitrate; Male; Middle Aged; Nitric Oxide; Pulmonary Circulation; Shock, Cardiogenic; Spironolactone; Vasodilator Agents | 1974 |
[Conservative therapy of angina pectoris].
Topics: Acute Disease; Amyl Nitrite; Angina Pectoris; Anticoagulants; Coronary Disease; Digitalis Glycosides; Furans; Heart Failure; Humans; Hypotension, Orthostatic; Isosorbide Dinitrate; Morphine; Myocardial Infarction; Nitrates; Nitrites; Nitroglycerin; Pentaerythritol Tetranitrate; Propranolol; Rest; Sympatholytics; Syncope; Vascular Headaches | 1970 |
Intermittent severe mitral regurgitation.
Topics: Acute Disease; Blood Pressure; Cardiac Catheterization; Chronic Disease; Digitalis Glycosides; Electrocardiography; Heart Auscultation; Heart Diseases; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Mitral Valve Insufficiency; Papillary Muscles; Pulmonary Artery; Pulmonary Edema | 1970 |